Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

David Peter Steensma, M.D.

Title
Institution
Department
Address
Phone
Fax
Profile Picture

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
List All   |   Timeline
  1. Steensma DP. Clinical consequences of clonal hematopoiesis of indeterminate potential. Hematology Am Soc Hematol Educ Program. 2018 11 30; 2018(1):264-269. PMID: 30504320.
    View in: PubMed
  2. Steensma DP. Clinical consequences of clonal hematopoiesis of indeterminate potential. Blood Adv. 2018 Nov 27; 2(22):3404-3410. PMID: 30482770.
    View in: PubMed
  3. Platzbecker U, Fenaux P, Adès L, Giagounidis A, Santini V, van de Loosdrecht AA, Bowen D, de Witte T, Garcia-Manero G, Hellström-Lindberg E, Germing U, Stauder R, Malcovati L, Sekeres M, Steensma DP, Gloaguen S. Proposals for revised IWG 2018 hematological response criteria in patients with MDS included in clinical trials. Blood. 2018 Nov 07. PMID: 30404811.
    View in: PubMed
  4. Kyle RA, Steensma DP. Herman Boerhaave - Master Clinician and Humanist. Mayo Clin Proc. 2018 Nov; 93(11):e119-e120. PMID: 30392557.
    View in: PubMed
  5. Steensma DP, Brunner AM, DeZern AE, Garcia-Manero G, Komrokji RS, Odenike OS, Roboz GJ, Savona MR, Stone RM, Sekeres MA. Low clinical trial accrual of patients with myelodysplastic syndromes: Causes and potential solutions. Cancer. 2018 Dec 15; 124(24):4601-4609. PMID: 30289970.
    View in: PubMed
  6. Benton CB, Khan M, Sallman D, Nazha A, Nogueras González GM, Piao J, Ning J, Aung F, Al Ali N, Jabbour E, Kadia TM, Borthakur G, Ravandi F, Pierce S, Steensma D, DeZern A, Roboz G, Sekeres M, Andreeff M, Kantarjian H, Komrokji RS, Garcia-Manero G. Prognosis of patients with intermediate risk IPSS-R myelodysplastic syndrome indicates variable outcomes and need for models beyond IPSS-R. Am J Hematol. 2018 Oct; 93(10):1245-1253. PMID: 30051599.
    View in: PubMed
  7. Steensma DP. An RNA bestiary in splicing-mutant MDS. Blood. 2018 Sep 20; 132(12):1217-1219. PMID: 30237252.
    View in: PubMed
  8. Steensma DP. How I use molecular genetic tests to evaluate patients who have or may have myelodysplastic syndromes. Blood. 2018 Oct 18; 132(16):1657-1663. PMID: 30185432.
    View in: PubMed
  9. Afshar A, Steensma DP, Kyle RA. Werner Forssmann: A Pioneer of Interventional Cardiology and Auto-Experimentation. Mayo Clin Proc. 2018 Sep; 93(9):e97-e98. PMID: 30193685.
    View in: PubMed
  10. Brunner AM, Weng S, Cronin A, Fathi AT, Habib AR, Stone R, Graubert T, Steensma DP, Abel GA. Impact of lenalidomide use among non-transfusion dependent patients with myelodysplastic syndromes. Am J Hematol. 2018 Sep; 93(9):1119-1126. PMID: 30033577.
    View in: PubMed
  11. El-Jawahri A, Nelson-Lowe M, VanDusen H, Traeger L, Abel GA, Greer JA, Fathi A, Steensma DP, LeBlanc TW, Li Z, DeAngelo D, Wadleigh M, Hobbs G, Foster J, Brunner A, Amrein P, Stone RM, Temel JS. Patient-Clinician Discordance in Perceptions of Treatment Risks and Benefits in Older Patients with Acute Myeloid Leukemia. Oncologist. 2018 Aug 23. PMID: 30139841.
    View in: PubMed
  12. Zhang Q, Steensma DP, Yang J, Dong T, Wu MX. Uncoupling of CD71 shedding with mitochondrial clearance in reticulocytes in a subset of myelodysplastic syndromes. Leukemia. 2018 Jul 26. PMID: 30050123.
    View in: PubMed
  13. Stahl M, DeVeaux M, de Witte T, Neukirchen J, Sekeres MA, Brunner AM, Roboz GJ, Steensma DP, Bhatt VR, Platzbecker U, Cluzeau T, Prata PH, Itzykson R, Fenaux P, Fathi AT, Smith A, Germing U, Ritchie EK, Verma V, Nazha A, Maciejewski JP, Podoltsev NA, Prebet T, Santini V, Gore SD, Komrokji RS, Zeidan AM. The use of immunosuppressive therapy in MDS: clinical outcomes and their predictors in a large international patient cohort. Blood Adv. 2018 Jul 24; 2(14):1765-1772. PMID: 30037803.
    View in: PubMed
  14. Ma X, Steensma DP, Scott BL, Kiselev P, Sugrue MM, Swern AS. Selection of patients with myelodysplastic syndromes from a large electronic medical records database and a study of the use of disease-modifying therapy in the United States. BMJ Open. 2018 Jul 23; 8(7):e019955. PMID: 30037860.
    View in: PubMed
  15. Riley LG, Heeney MM, Rudinger-Thirion J, Frugier M, Campagna DR, Zhou R, Hale GA, Hilliard LM, Kaplan JA, Kwiatkowski JL, Sieff CA, Steensma DP, Rennings AJ, Simons A, Schaap N, Roodenburg RJ, Kleefstra T, Arenillas L, Fita-Torró J, Ahmed R, Abboud M, Bechara E, Farah R, Tamminga RY, Bottomley SS, Sanchez M, Swinkels DW, Christodoulou J, Fleming MD. The phenotypic spectrum of germline YARS2 variants: from isolated sideroblastic anemia to mitochondrial myopathy, lactic acidosis and sideroblastic anemia 2. Haematologica. 2018 Jul 19. PMID: 30026338.
    View in: PubMed
  16. Steensma DP. Clinical Implications of Clonal Hematopoiesis. Mayo Clin Proc. 2018 Aug; 93(8):1122-1130. PMID: 30078412.
    View in: PubMed
  17. Steensma DP, Roede CA, Kyle RA. Henry David Thoreau's Final Journey: Minnesota. Mayo Clin Proc. 2018 Jul; 93(7):e75-e76. PMID: 29976384.
    View in: PubMed
  18. Migdady Y, Barnard J, Al Ali N, Steensma DP, DeZern A, Roboz G, Garcia-Manero G, Sekeres MA, Komrokji RS. Clinical Outcomes With Ring Sideroblasts and SF3B1 Mutations in Myelodysplastic Syndromes: MDS Clinical Research Consortium Analysis. Clin Lymphoma Myeloma Leuk. 2018 Aug; 18(8):528-532. PMID: 29937400.
    View in: PubMed
  19. Steensma DP. Myelodysplastic syndromes current treatment algorithm 2018. Blood Cancer J. 2018 May 24; 8(5):47. PMID: 29795386.
    View in: PubMed
  20. Kantarjian HM, Prat F, Steensma DP, Kurzrock R, Stewart DJ, Sekeres MA, Leveque J. Cancer research in the United States: A critical review of current status and proposal for alternative models. Cancer. 2018 Jul 15; 124(14):2881-2889. PMID: 29757456.
    View in: PubMed
  21. Mehm AR, Steensma DP, Srouji SS, Ginsburg ES, Brady PC. Fertility preservation in women with marrow failure syndromes prior to allogeneic stem cell transplantation. Am J Hematol. 2018 May 13. PMID: 29756247.
    View in: PubMed
  22. Patel SS, Kuo FC, Gibson CJ, Steensma DP, Soiffer RJ, Alyea EP, Chen YA, Fathi AT, Graubert TA, Brunner AM, Wadleigh M, Stone RM, DeAngelo DJ, Nardi V, Hasserjian RP, Weinberg OK. High NPM1-mutant allele burden at diagnosis predicts unfavorable outcomes in de novo AML. Blood. 2018 Jun 21; 131(25):2816-2825. PMID: 29724895.
    View in: PubMed
  23. Kyle RA, Steensma DP. Jöns Jacob Berzelius - A Father of Chemistry. Mayo Clin Proc. 2018 May; 93(5):e53-e54. PMID: 29728209.
    View in: PubMed
  24. Gibson CJ, Steensma DP. New Insights from Studies of Clonal Hematopoiesis. Clin Cancer Res. 2018 Oct 01; 24(19):4633-4642. PMID: 29703819.
    View in: PubMed
  25. Stahl M, Pine A, Hendrickson JE, Litzow MR, Luger SM, Stone RM, Erba HP, Kim TK, Sekeres MA, Steensma DP, Komrokji RS, Gore SD, Zeidan AM. Beliefs and practice patterns in hyperleukocytosis management in acute myeloid leukemia: a large U.S. web-based survey. Leuk Lymphoma. 2018 Apr 18; 1-4. PMID: 29667455.
    View in: PubMed
  26. Wolach O, Sellar RS, Martinod K, Cherpokova D, McConkey M, Chappell RJ, Silver AJ, Adams D, Castellano CA, Schneider RK, Padera RF, DeAngelo DJ, Wadleigh M, Steensma DP, Galinsky I, Stone RM, Genovese G, McCarroll SA, Iliadou B, Hultman C, Neuberg D, Mullally A, Wagner DD, Ebert BL. Increased neutrophil extracellular trap formation promotes thrombosis in myeloproliferative neoplasms. Sci Transl Med. 2018 Apr 11; 10(436). PMID: 29643232.
    View in: PubMed
  27. Steensma DP, Ebert BL. Clonal Hematopoiesis after Induction Chemotherapy for Acute Myeloid Leukemia. N Engl J Med. 2018 03 29; 378(13):1244-1245. PMID: 29590545.
    View in: PubMed
  28. Kyle RA, Steensma DP. Christian Albert Theodor Billroth: Founder of Abdominal Surgery. Mayo Clin Proc. 2018 Mar; 93(3):e29-e30. PMID: 29502575.
    View in: PubMed
  29. Steensma DP. Prognosis in myelodysplastic syndromes: The attractions and limitations of simplicity. Am J Hematol. 2018 May; 93(5):605-606. PMID: 29451319.
    View in: PubMed
  30. Komrokji R, Garcia-Manero G, Ades L, Prebet T, Steensma DP, Jurcic JG, Sekeres MA, Berdeja J, Savona MR, Beyne-Rauzy O, Stamatoullas A, DeZern AE, Delaunay J, Borthakur G, Rifkin R, Boyd TE, Laadem A, Vo B, Zhang J, Puccio-Pick M, Attie KM, Fenaux P, List AF. Sotatercept with long-term extension for the treatment of anaemia in patients with lower-risk myelodysplastic syndromes: a phase 2, dose-ranging trial. Lancet Haematol. 2018 Feb; 5(2):e63-e72. PMID: 29331635.
    View in: PubMed
  31. Ghobrial IM, Detappe A, Anderson KC, Steensma DP. The bone-marrow niche in MDS and MGUS: implications for AML and MM. Nat Rev Clin Oncol. 2018 Apr; 15(4):219-233. PMID: 29311715.
    View in: PubMed
  32. Afshar A, Steensma DP, Kyle RA. Álvaro Alvim-Radiologist and Brazilian "Martyr to Science". Mayo Clin Proc. 2018 01; 93(1):e7. PMID: 29304925.
    View in: PubMed
  33. Brunner AM, Steensma DP. Recent advances in the cellular and molecular understanding of myelodysplastic syndromes: implications for new therapeutic approaches. Clin Adv Hematol Oncol. 2018 Jan; 16(1):56-66. PMID: 29741506.
    View in: PubMed
  34. Nazha A, Sekeres MA, Komrokji R, Steensma DP, Kantarjian H, Roboz G, Fenaux P, Prebet T, Azarnia N, Zbyszewski PS, Fruchtman SM, Santini V, Silverman LR, Platzbecker U, Garcia-Manero G. Validation of a post-hypomethylating agent failure prognostic model in myelodysplastic syndromes patients treated in a randomized controlled phase III trial of rigosertib vs. best supportive care. Blood Cancer J. 2017 12 14; 7(12):644. PMID: 29238044.
    View in: PubMed
  35. Steensma DP. The Raven. J Clin Oncol. 2018 Feb 10; 36(5):512-513. PMID: 29236583.
    View in: PubMed
  36. DeAngelo DJ, Brunner AM, Werner L, Avigan D, Fathi AT, Sperling AS, Washington A, Stroopinsky D, Rosenblatt J, McMasters M, Luptakova K, Wadleigh M, Steensma DP, Hobbs GS, Attar EC, Amrein PC, Ebert BL, Stone RM, Ballen KK. A phase I study of lenalidomide plus chemotherapy with mitoxantrone, etoposide, and cytarabine for the reinduction of patients with acute myeloid leukemia. Am J Hematol. 2018 02; 93(2):254-261. PMID: 29119643.
    View in: PubMed
  37. Siddiqui S, Steensma DP, Kyle RA. Thalassemia and Thomas Benton Cooley. Mayo Clin Proc. 2017 11; 92(11):e161-e162. PMID: 29101943.
    View in: PubMed
  38. Brunner AM, Blonquist TM, Hobbs GS, Amrein PC, Neuberg DS, Steensma DP, Abel GA, Fathi AT. Risk and timing of cardiovascular death among patients with myelodysplastic syndromes. Blood Adv. 2017 Oct 24; 1(23):2032-2040. PMID: 29296849.
    View in: PubMed
  39. Steensma DP. The evolving role of genomic testing in assessing prognosis of patients with myelodysplastic syndromes. Best Pract Res Clin Haematol. 2017 12; 30(4):295-300. PMID: 29156198.
    View in: PubMed
  40. Morgan EA, Lee MN, DeAngelo DJ, Steensma DP, Stone RM, Kuo FC, Aster JC, Gibson CJ, Lindsley RC. Systematic STAT3 sequencing in patients with unexplained cytopenias identifies unsuspected large granular lymphocytic leukemia. Blood Adv. 2017 Sep 26; 1(21):1786-1789. PMID: 29296824.
    View in: PubMed
  41. Steensma DP, Kyle RA. Charles Fletcher, The Centaur Company, and Proprietary Medicine Revenue Stamps. Mayo Clin Proc. 2017 09; 92(9):e127-e128. PMID: 28870369.
    View in: PubMed
  42. Jabbour E, Short NJ, Montalban-Bravo G, Huang X, Bueso-Ramos C, Qiao W, Yang H, Zhao C, Kadia T, Borthakur G, Pemmaraju N, Sasaki K, Estrov Z, Cortes J, Ravandi F, Alvarado Y, Komrokji R, Sekeres MA, Steensma DP, DeZern A, Roboz G, Kantarjian H, Garcia-Manero G. Randomized phase 2 study of low-dose decitabine vs low-dose azacitidine in lower-risk MDS and MDS/MPN. Blood. 2017 09 28; 130(13):1514-1522. PMID: 28774880.
    View in: PubMed
  43. Zeidan AM, Sekeres MA, Barnard J, Steensma DP, Komrokji R. Therapy-related myelodysplastic syndromes-specific risk stratification: are we putting the cart before the horse? Leukemia. 2017 11; 31(11):2539-2541. PMID: 28757618.
    View in: PubMed
  44. Zeidan AM, Stahl M, Sekeres MA, Steensma DP, Komrokji RS, Gore SD. A call for action: Increasing enrollment of untreated patients with higher-risk myelodysplastic syndromes in first-line clinical trials. Cancer. 2017 Oct 01; 123(19):3662-3672. PMID: 28759108.
    View in: PubMed
  45. Valent P, Orazi A, Steensma DP, Ebert BL, Haase D, Malcovati L, van de Loosdrecht AA, Haferlach T, Westers TM, Wells DA, Giagounidis A, Loken M, Orfao A, Lübbert M, Ganser A, Hofmann WK, Ogata K, Schanz J, Béné MC, Hoermann G, Sperr WR, Sotlar K, Bettelheim P, Stauder R, Pfeilstöcker M, Horny HP, Germing U, Greenberg P, Bennett JM. Proposed minimal diagnostic criteria for myelodysplastic syndromes (MDS) and potential pre-MDS conditions. Oncotarget. 2017 Sep 26; 8(43):73483-73500. PMID: 29088721.
    View in: PubMed
  46. Afshar A, Kyle RA, Steensma DP. Adolf Lorenz - The Bloodless Surgeon of Vienna. Mayo Clin Proc. 2017 07; 92(7):e105-e106. PMID: 28688475.
    View in: PubMed
  47. Afshar A, Steensma DP, Kyle RA. Antonius Mathijsen and Plaster Casts. Mayo Clin Proc. 2017 05; 92(5):e83. PMID: 28473048.
    View in: PubMed
  48. Park S, Hamel JF, Toma A, Kelaidi C, Thépot S, Campelo MD, Santini V, Sekeres MA, Balleari E, Kaivers J, Sapena R, Götze K, Müller-Thomas C, Beyne-Rauzy O, Stamatoullas A, Kotsianidis I, Komrokji R, Steensma DP, Fensterl J, Roboz GJ, Bernal T, Ramos F, Calabuig M, Guerci-Bresler A, Bordessoule D, Cony-Makhoul P, Cheze S, Wattel E, Rose C, Vey N, Gioia D, Ferrero D, Gaidano G, Cametti G, Pane F, Sanna A, Germing U, Sanz GF, Dreyfus F, Fenaux P. Outcome of Lower-Risk Patients With Myelodysplastic Syndromes Without 5q Deletion After Failure of Erythropoiesis-Stimulating Agents. J Clin Oncol. 2017 May 10; 35(14):1591-1597. PMID: 28350519.
    View in: PubMed
  49. Luskin MR, Cronin AM, Owens RL, DeAngelo DJ, Stone RM, Wadleigh M, Steensma DP, Abel GA. Self-reported sleep disturbance and survival in myelodysplastic syndromes. Br J Haematol. 2017 05; 177(4):562-566. PMID: 28272741.
    View in: PubMed
  50. Steensma DP. The origin and evolution of the term "clone". Leuk Res. 2017 06; 57:97-101. PMID: 28340380.
    View in: PubMed
  51. Steensma DP, Kyle RA. Van Gogh's Portrait of Dr Gachet. Mayo Clin Proc. 2017 Mar; 92(3):e57-e58. PMID: 28259236.
    View in: PubMed
  52. Kuo FC, Steensma DP, Dal Cin P. Conventional cytogenetics for myeloid neoplasms in the era of next-generation-sequencing. Am J Hematol. 2017 Mar; 92(3):227-229. PMID: 28054397.
    View in: PubMed
  53. Zeidan AM, Al Ali N, Barnard J, Padron E, Lancet JE, Sekeres MA, Steensma DP, DeZern A, Roboz G, Jabbour E, Garcia-Manero G, List A, Komrokji R. Comparison of clinical outcomes and prognostic utility of risk stratification tools in patients with therapy-related vs de novo myelodysplastic syndromes: a report on behalf of the MDS Clinical Research Consortium. Leukemia. 2017 06; 31(6):1391-1397. PMID: 28111463.
    View in: PubMed
  54. Steensma DP, Kyle RA. The Medical Doctors of Star Trek: Leonard "Bones" McCoy and Beverly Crusher. Mayo Clin Proc. 2017 01; 92(1):e9-e10. PMID: 28062069.
    View in: PubMed
  55. Rosenblatt J, Stone RM, Uhl L, Neuberg D, Joyce R, Levine JD, Arnason J, McMasters M, Luptakova K, Jain S, Zwicker JI, Hamdan A, Boussiotis V, Steensma DP, DeAngelo DJ, Galinsky I, Dutt PS, Logan E, Bryant MP, Stroopinsky D, Werner L, Palmer K, Coll M, Washington A, Cole L, Kufe D, Avigan D. Individualized vaccination of AML patients in remission is associated with induction of antileukemia immunity and prolonged remissions. Sci Transl Med. 2016 12 07; 8(368):368ra171. PMID: 27928025.
    View in: PubMed
  56. Steensma DP. Predicting therapy-related myeloid neoplasms-and preventing them? Lancet Oncol. 2017 01; 18(1):11-13. PMID: 27927581.
    View in: PubMed
  57. Steensma DP. New challenges in evaluating anemia in older persons in the era of molecular testing. Hematology Am Soc Hematol Educ Program. 2016 Dec 02; 2016(1):67-73. PMID: 27913464.
    View in: PubMed
  58. Brierley CK, Steensma DP. Targeting Splicing in the Treatment of Myelodysplastic Syndromes and Other Myeloid Neoplasms. Curr Hematol Malig Rep. 2016 12; 11(6):408-415. PMID: 27492253.
    View in: PubMed
  59. Steensma DP, Kyle RA. Hendrik van Deventer: Dutch Obstetrician and Orthopedist. Mayo Clin Proc. 2016 12; 91(12):e171. PMID: 27916164.
    View in: PubMed
  60. Pine AB, Lee EJ, Sekeres M, Steensma DP, Zelterman D, Prebet T, DeZern A, Komrokji R, Litzow M, Luger S, Stone R, Erba HP, Garcia-Manero G, Lee AI, Podoltsev NA, Barbarotta L, Kasberg S, Hendrickson JE, Gore SD, Zeidan AM. Wide variations in blood product transfusion practices among providers who care for patients with acute leukemia in the United States. Transfusion. 2017 02; 57(2):289-295. PMID: 27878822.
    View in: PubMed
  61. DeZern AE, Zeidan AM, Barnard J, Hand W, Al Ali N, Brown F, Zimmerman C, Roboz GJ, Garcia-Manero G, Steensma DP, Komrokji RS, Sekeres MA. Differential response to hypomethylating agents based on sex: a report on behalf of the MDS Clinical Research Consortium (MDS CRC). Leuk Lymphoma. 2017 06; 58(6):1325-1331. PMID: 27774847.
    View in: PubMed
  62. Zeidan AM, Xu M, Steensma DP. The importance of erythroblast enumeration in myeloid neoplasia. Ann Hematol. 2017 Feb; 96(2):329-330. PMID: 27771743.
    View in: PubMed
  63. Steensma DP. Good riddance to the term "refractory anemia" in myelodysplastic syndromes. Leuk Res. 2016 12; 51:22-26. PMID: 27776290.
    View in: PubMed
  64. Ruiz-Argüelles GJ, Steensma DP. Staunching the rising costs of haematological health care. Lancet Haematol. 2016 Oct; 3(10):e455. PMID: 27692304.
    View in: PubMed
  65. Steensma DP. Putting it all together in CMML risk stratification. Blood. 2016 09 08; 128(10):1318-9. PMID: 27609540.
    View in: PubMed
  66. Steensma DP, Kyle RA, Shampo MA. J. Robin Warren: Helicobacter Pylori and Peptic Ulcer. Mayo Clin Proc. 2016 Sep; 91(9):e129-30. PMID: 27594194.
    View in: PubMed
  67. Bhatt VR, Steensma DP. Hematopoietic Cell Transplantation for Myelodysplastic Syndromes. J Oncol Pract. 2016 09; 12(9):786-92. PMID: 27621329.
    View in: PubMed
  68. Steensma DP, Abedi M, Bejar R, Cogle CR, Foucar K, Garcia-Manero G, George TI, Grinblatt D, Komrokji R, Ma X, Maciejewski J, Pollyea DA, Savona MR, Scott B, Sekeres MA, Thompson MA, Swern AS, Nifenecker M, Sugrue MM, Erba H. Connect MDS/AML: design of the myelodysplastic syndromes and acute myeloid leukemia disease registry, a prospective observational cohort study. BMC Cancer. 2016 08 19; 16:652. PMID: 27538433; PMCID: PMC4991094.
  69. Wang SA, Patel KP, Pozdnyakova O, Peng J, Zuo Z, Dal Cin P, Steensma DP, Hasserjian RP. Acute erythroid leukemia with <20% bone marrow blasts is clinically and biologically similar to myelodysplastic syndrome with excess blasts. Mod Pathol. 2016 10; 29(10):1221-31. PMID: 27443511.
    View in: PubMed
  70. Townsend EC, Murakami MA, Christodoulou A, Christie AL, Köster J, DeSouza TA, Morgan EA, Kallgren SP, Liu H, Wu SC, Plana O, Montero J, Stevenson KE, Rao P, Vadhi R, Andreeff M, Armand P, Ballen KK, Barzaghi-Rinaudo P, Cahill S, Clark RA, Cooke VG, Davids MS, DeAngelo DJ, Dorfman DM, Eaton H, Ebert BL, Etchin J, Firestone B, Fisher DC, Freedman AS, Galinsky IA, Gao H, Garcia JS, Garnache-Ottou F, Graubert TA, Gutierrez A, Halilovic E, Harris MH, Herbert ZT, Horwitz SM, Inghirami G, Intlekofer AM, Ito M, Izraeli S, Jacobsen ED, Jacobson CA, Jeay S, Jeremias I, Kelliher MA, Koch R, Konopleva M, Kopp N, Kornblau SM, Kung AL, Kupper TS, LeBoeuf NR, LaCasce AS, Lees E, Li LS, Look AT, Murakami M, Muschen M, Neuberg D, Ng SY, Odejide OO, Orkin SH, Paquette RR, Place AE, Roderick JE, Ryan JA, Sallan SE, Shoji B, Silverman LB, Soiffer RJ, Steensma DP, Stegmaier K, Stone RM, Tamburini J, Thorner AR, van Hummelen P, Wadleigh M, Wiesmann M, Weng AP, Wuerthner JU, Williams DA, Wollison BM, Lane AA, Letai A, Bertagnolli MM, Ritz J, Brown M, Long H, Aster JC, Shipp MA, Griffin JD, Weinstock DM. The Public Repository of Xenografts Enables Discovery and Randomized Phase II-like Trials in Mice. Cancer Cell. 2016 07 11; 30(1):183. PMID: 27479034.
    View in: PubMed
  71. Brunner AM, Steensma DP. Myelodysplastic syndrome associated with acquired beta thalassemia: "BTMDS". Am J Hematol. 2016 08; 91(8):E325-7. PMID: 27121565; PMCID: PMC4947000 [Available on 08/01/17].
  72. Steensma DP, Kyle RA, Shampo MA. Elizabeth Blackburn and Maintenance of Telomeres. Mayo Clin Proc. 2016 07; 91(7):e105. PMID: 27378050.
    View in: PubMed
  73. Wolach O, Stevenson KE, Wadleigh M, DeAngelo DJ, Steensma DP, Ballen KK, Soiffer RJ, Antin JH, Neuberg DS, Ho VT, Stone RM. Allogeneic transplantation is not superior to chemotherapy in most patients over 40 years of age with Philadelphia-negative acute lymphoblastic leukemia in first remission. Am J Hematol. 2016 08; 91(8):793-9. PMID: 27153389.
    View in: PubMed
  74. El-Jawahri A, Keenan T, Abel GA, Steensma DP, LeBlanc TW, Chen YB, Hobbs G, Traeger L, Fathi AT, DeAngelo DJ, Wadleigh M, Ballen KK, Amrein PC, Stone RM, Temel JS. Potentially avoidable hospital admissions in older patients with acute myeloid leukaemia in the USA: a retrospective analysis. Lancet Haematol. 2016 Jun; 3(6):e276-83. PMID: 27264037.
    View in: PubMed
  75. Fathi AT, DeAngelo DJ, Stevenson KE, Kolitz JE, Asch JD, Amrein PC, Attar EC, Steensma DP, Wadleigh M, Foster J, Connolly C, Galinsky I, Devoe CE, Stone RM, Neuberg DS, Ballen KK. Phase 2 study of intensified chemotherapy and allogeneic hematopoietic stem cell transplantation for older patients with acute lymphoblastic leukemia. Cancer. 2016 Aug 01; 122(15):2379-88. PMID: 27171984.
    View in: PubMed
  76. Kyle RA, Steensma DP, Shampo MA. Barry James Marshall-Discovery of Helicobacter pylori as a Cause of Peptic Ulcer. Mayo Clin Proc. 2016 05; 91(5):e67-8. PMID: 27150219.
    View in: PubMed
  77. Stahl M, Xu ML, Steensma DP, Rampal R, Much M, Zeidan AM. Clinical response to ruxolitinib in CSF3R T618-mutated chronic neutrophilic leukemia. Ann Hematol. 2016 Jun; 95(7):1197-200. PMID: 27068405.
    View in: PubMed
  78. Townsend EC, Murakami MA, Christodoulou A, Christie AL, Köster J, DeSouza TA, Morgan EA, Kallgren SP, Liu H, Wu SC, Plana O, Montero J, Stevenson KE, Rao P, Vadhi R, Andreeff M, Armand P, Ballen KK, Barzaghi-Rinaudo P, Cahill S, Clark RA, Cooke VG, Davids MS, DeAngelo DJ, Dorfman DM, Eaton H, Ebert BL, Etchin J, Firestone B, Fisher DC, Freedman AS, Galinsky IA, Gao H, Garcia JS, Garnache-Ottou F, Graubert TA, Gutierrez A, Halilovic E, Harris MH, Herbert ZT, Horwitz SM, Inghirami G, Intlekofer AM, Ito M, Izraeli S, Jacobsen ED, Jacobson CA, Jeay S, Jeremias I, Kelliher MA, Koch R, Konopleva M, Kopp N, Kornblau SM, Kung AL, Kupper TS, LeBoeuf NR, LaCasce AS, Lees E, Li LS, Look AT, Murakami M, Muschen M, Neuberg D, Ng SY, Odejide OO, Orkin SH, Paquette RR, Place AE, Roderick JE, Ryan JA, Sallan SE, Shoji B, Silverman LB, Soiffer RJ, Steensma DP, Stegmaier K, Stone RM, Tamburini J, Thorner AR, van Hummelen P, Wadleigh M, Wiesmann M, Weng AP, Wuerthner JU, Williams DA, Wollison BM, Lane AA, Letai A, Bertagnolli MM, Ritz J, Brown M, Long H, Aster JC, Shipp MA, Griffin JD, Weinstock DM. The Public Repository of Xenografts Enables Discovery and Randomized Phase II-like Trials in Mice. Cancer Cell. 2016 04 11; 29(4):574-586. PMID: 27070704.
    View in: PubMed
  79. Roberts DA, Kantarjian HM, Steensma DP. Contract research organizations in oncology clinical research: Challenges and opportunities. Cancer. 2016 May 15; 122(10):1476-82. PMID: 27018651.
    View in: PubMed
  80. El-Jawahri A, Kim HT, Steensma DP, Cronin AM, Stone RM, Watts CD, Chen YB, Cutler CS, Soiffer RJ, Abel GA. Does quality of life impact the decision to pursue stem cell transplantation for elderly patients with advanced MDS? Bone Marrow Transplant. 2016 Aug; 51(8):1121-6. PMID: 26999469.
    View in: PubMed
  81. Nazha A, Komrokji RS, Garcia-Manero G, Barnard J, Roboz GJ, Steensma DP, DeZern AE, Zell K, Zimmerman C, Ali NA, Jabbour E, Greenberg MD, Kantarjian HM, Maciejewski JP, List AF, Sekeres MA. The efficacy of current prognostic models in predicting outcome of patients with myelodysplastic syndromes at the time of hypomethylating agent failure. Haematologica. 2016 06; 101(6):e224-7. PMID: 26992944; PMCID: PMC5013943.
  82. Garcia-Manero G, Fenaux P, Al-Kali A, Baer MR, Sekeres MA, Roboz GJ, Gaidano G, Scott BL, Greenberg P, Platzbecker U, Steensma DP, Kambhampati S, Kreuzer KA, Godley LA, Atallah E, Collins R, Kantarjian H, Jabbour E, Wilhelm FE, Azarnia N, Silverman LR. Rigosertib versus best supportive care for patients with high-risk myelodysplastic syndromes after failure of hypomethylating drugs (ONTIME): a randomised, controlled, phase 3 trial. Lancet Oncol. 2016 Apr; 17(4):496-508. PMID: 26968357.
    View in: PubMed
  83. Abel GA, Efficace F, Buckstein RJ, Tinsley S, Jurcic JG, Martins Y, Steensma DP, Watts CD, Raza A, Lee SJ, List AF, Klaassen RJ. Prospective international validation of the Quality of Life in Myelodysplasia Scale (QUALMS). Haematologica. 2016 06; 101(6):781-8. PMID: 26944474; PMCID: PMC5013948.
  84. Brierley CK, Steensma DP. Allogeneic stem cell transplantation in myelodysplastic syndromes: does pretransplant clonal burden matter? Curr Opin Hematol. 2016 Mar; 23(2):167-74. PMID: 26717194.
    View in: PubMed
  85. Kyle RA, Steensma DP, Shampo MA. Otto Wichterle--Inventor of the First Soft Contact Lenses. Mayo Clin Proc. 2016 Mar; 91(3):e45-6. PMID: 26944252.
    View in: PubMed
  86. Fletcher SA, Cronin AM, Zeidan AM, Odejide OO, Gore SD, Davidoff AJ, Steensma DP, Abel GA. Intensity of end-of-life care for patients with myelodysplastic syndromes: Findings from a large national database. Cancer. 2016 Apr 15; 122(8):1209-15. PMID: 26914833.
    View in: PubMed
  87. Jain N, Steensma D, Stewart DJ, Kantarjian H. Insurance Denial of Coverage for Patients Enrolled in Cancer Clinical Trials Is Still a Problem in the Affordable Care Act Era. J Oncol Pract. 2016 Apr; 12(4):283-5. PMID: 26907450.
    View in: PubMed
  88. Abel GA, Cronin AM, Odejide OO, Uno H, Stone RM, Steensma DP. Influence of patient and provider characteristics on quality of care for the myelodysplastic syndromes. Br J Haematol. 2016 06; 173(5):713-21. PMID: 26913376.
    View in: PubMed
  89. Padron E, Dezern A, Andrade-Campos M, Vaddi K, Scherle P, Zhang Q, Ma Y, Balasis ME, Tinsley S, Ramadan H, Zimmerman C, Steensma DP, Roboz GJ, Lancet JE, List AF, Sekeres MA, Komrokji RS. A Multi-Institution Phase I Trial of Ruxolitinib in Patients with Chronic Myelomonocytic Leukemia (CMML). Clin Cancer Res. 2016 08 01; 22(15):3746-54. PMID: 26858309.
    View in: PubMed
  90. Steensma DP. The Farid Fata Medicare Fraud Case and Misplaced Incentives in Oncology Care. J Oncol Pract. 2016 Jan; 12(1):51-4. PMID: 26733620.
    View in: PubMed
  91. Nazha A, Sekeres MA, Garcia-Manero G, Barnard J, Al Ali NH, Roboz GJ, Steensma DP, DeZern AE, Zimmerman C, Jabbour EJ, Zell K, List AF, Kantarjian HM, Maciejewski JP, Komrokji RS. Outcomes of patients with myelodysplastic syndromes who achieve stable disease after treatment with hypomethylating agents. Leuk Res. 2016 Feb; 41:43-7. PMID: 26777537; PMCID: PMC4986515.
  92. Kyle RA, Steensma DP, Shampo MA. Friedrich August Johannes Löffler (Loeffler), German Bacteriologist. Mayo Clin Proc. 2015 Dec; 90(12):e135. PMID: 26653308.
    View in: PubMed
  93. Steensma DP. Cytopenias + mutations - dysplasia = what? Blood. 2015 Nov 19; 126(21):2349-51. PMID: 26585803.
    View in: PubMed
  94. Zeidan AM, Sekeres MA, Wang XF, Al Ali N, Garcia-Manero G, Steensma DP, Roboz G, Barnard J, Padron E, DeZern A, Maciejewski JP, List AF, Komrokji RS. Comparing the prognostic value of risk stratifying models for patients with lower-risk myelodysplastic syndromes: Is one model better? Am J Hematol. 2015 Nov; 90(11):1036-40. PMID: 26284571.
    View in: PubMed
  95. Zeidan AM, Sekeres MA, Garcia-Manero G, Steensma DP, Zell K, Barnard J, Ali NA, Zimmerman C, Roboz G, DeZern A, Nazha A, Jabbour E, Kantarjian H, Gore SD, Maciejewski JP, List A, Komrokji R. Comparison of risk stratification tools in predicting outcomes of patients with higher-risk myelodysplastic syndromes treated with azanucleosides. Leukemia. 2016 Mar; 30(3):649-57. PMID: 26464171; PMCID: PMC4775363.
  96. Cronin A, Watts CD, Steensma DP, Stone RM, DeAngelo DJ, Owens RL, Wadleigh M, Abel GA. Impact of sleep disturbance in myelodysplastic syndromes (MDS). J Clin Oncol. 2015 Oct 10; 33(29_suppl):99. PMID: 28148038.
    View in: PubMed
  97. Keenan T, Abel GA, Steensma DP, LeBlanc TW, Traeger L, Fathi AT, DeAngelo DJ, Wadleigh M, Hobbs G, Amrein PC, Stone RM, Ballen KK, Chen YA, Temel JS. Potentially avoidable hospitalizations in older patients with acute myeloid leukemia (AML). J Clin Oncol. 2015 Oct 10; 33(29_suppl):206. PMID: 28148109.
    View in: PubMed
  98. Steensma DP. Graphical representation of clinical outcomes for patients with myelodysplastic syndromes. Leuk Lymphoma. 2016; 57(1):17-20. PMID: 26098015.
    View in: PubMed
  99. Steensma DP, Shampo MA, Kyle RA. Ernesto "Che" Guevara de la Serna: Argentinian Marxist Revolutionary. Mayo Clin Proc. 2015 Oct; 90(10):e111-2. PMID: 26434975.
    View in: PubMed
  100. Li W, Croce K, Steensma DP, McDermott DF, Ben-Yehuda O, Moslehi J. Vascular and Metabolic Implications of Novel Targeted Cancer Therapies: Focus on Kinase Inhibitors. J Am Coll Cardiol. 2015 Sep 08; 66(10):1160-78. PMID: 26337996.
    View in: PubMed
  101. Roberts DA, Steensma DP. Outlook and Management of Patients with Myelodysplastic Syndromes Failed by Hypomethylating Agents. Curr Hematol Malig Rep. 2015 Sep; 10(3):318-28. PMID: 26126600.
    View in: PubMed
  102. Steensma DP, Dakhil SR, Novotny PJ, Sloan JA, Johnson DB, Anderson DM, Mattar BI, Moore DF, Nikcevich D, Loprinzi CL. A randomized comparison of once weekly epoetin alfa to extended schedule epoetin or darbepoetin in chemotherapy-associated anemia. Am J Hematol. 2015 Oct; 90(10):877-81. PMID: 26149465.
    View in: PubMed
  103. Zeidan AM, Sekeres MA, Wang XF, Al Ali N, Garcia-Manero G, Steensma DP, Roboz G, Barnard J, Padron E, Dezern A, Maciejewski JP, List AF, Komrokji RS. Comparing the Prognostic Value of Risk stratifying Models for Patients with Lower-Risk Myelodysplastic Syndromes: Is one model better? Am J Hematol. 2015 Aug 11. PMID: 26260295.
    View in: PubMed
  104. Steensma DP. Key Opinion Leaders. J Clin Oncol. 2015 Oct 01; 33(28):3213-4. PMID: 26261246.
    View in: PubMed
  105. Steensma DP, Shampo MA, Kyle RA. Max Perutz and the Structure of Hemoglobin. Mayo Clin Proc. 2015 Aug; 90(8):e89. PMID: 26250737.
    View in: PubMed
  106. Tefferi A, Kantarjian H, Rajkumar SV, Baker LH, Abkowitz JL, Adamson JW, Advani RH, Allison J, Antman KH, Bast RC, Bennett JM, Benz EJ, Berliner N, Bertino J, Bhatia R, Bhatia S, Bhojwani D, Blanke CD, Bloomfield CD, Bosserman L, Broxmeyer HE, Byrd JC, Cabanillas F, Canellos GP, Chabner BA, Chanan-Khan A, Cheson B, Clarkson B, Cohn SL, Colon-Otero G, Cortes J, Coutre S, Cristofanilli M, Curran WJ, Daley GQ, DeAngelo DJ, Deeg HJ, Einhorn LH, Erba HP, Esteva FJ, Estey E, Fidler IJ, Foran J, Forman S, Freireich E, Fuchs C, George JN, Gertz MA, Giralt S, Golomb H, Greenberg P, Gutterman J, Handin RI, Hellman S, Hoff PM, Hoffman R, Hong WK, Horowitz M, Hortobagyi GN, Hudis C, Issa JP, Johnson BE, Kantoff PW, Kaushansky K, Khayat D, Khuri FR, Kipps TJ, Kripke M, Kyle RA, Larson RA, Lawrence TS, Levine R, Link MP, Lippman SM, Lonial S, Lyman GH, Markman M, Mendelsohn J, Meropol NJ, Messinger Y, Mulvey TM, O'Brien S, Perez-Soler R, Pollock R, Prchal J, Press O, Radich J, Rai K, Rosenberg SA, Rowe JM, Rugo H, Runowicz CD, Sandmaier BM, Saven A, Schafer AI, Schiffer C, Sekeres MA, Silver RT, Siu LL, Steensma DP, Stewart FM, Stock W, Stone R, Storb R, Strong LC, Tallman MS, Thompson M, Ueno NT, Van Etten RA, Vose JM, Wiernik PH, Winer EP, Younes A, Zelenetz AD, LeMaistre CA. In Support of a Patient-Driven Initiative and Petition to Lower the High Price of Cancer Drugs. Mayo Clin Proc. 2015 Aug; 90(8):996-1000. PMID: 26211600.
    View in: PubMed
  107. Jones GH, Tefferi A, Steensma D, Kantarjian H. The Hippocratic Oath, the US Health Care System, and the Affordable Care Act in 2015. Am J Med. 2015 Nov; 128(11):1162-4. PMID: 26184683.
    View in: PubMed
  108. Wu SC, Li LS, Kopp N, Montero J, Chapuy B, Yoda A, Christie AL, Liu H, Christodoulou A, van Bodegom D, van der Zwet J, Layer JV, Tivey T, Lane AA, Ryan JA, Ng SY, DeAngelo DJ, Stone RM, Steensma D, Wadleigh M, Harris M, Mandon E, Ebel N, Andraos R, Romanet V, Dölemeyer A, Sterker D, Zender M, Rodig SJ, Murakami M, Hofmann F, Kuo F, Eck MJ, Silverman LB, Sallan SE, Letai A, Baffert F, Vangrevelinghe E, Radimerski T, Gaul C, Weinstock DM. Activity of the Type II JAK2 Inhibitor CHZ868 in B Cell Acute Lymphoblastic Leukemia. Cancer Cell. 2015 Jul 13; 28(1):29-41. PMID: 26175414; PMCID: PMC4505625.
  109. Steensma DP. Myelodysplastic Syndromes: Diagnosis and Treatment. Mayo Clin Proc. 2015 Jul; 90(7):969-83. PMID: 26141335.
    View in: PubMed
  110. Fega KR, Abel GA, Motyckova G, Sherman AE, DeAngelo DJ, Steensma DP, Galinsky I, Wadleigh M, Stone RM, Driver JA. Non-hematologic predictors of mortality improve the prognostic value of the international prognostic scoring system for MDS in older adults. J Geriatr Oncol. 2015 Jul; 6(4):288-98. PMID: 26073533; PMCID: PMC4860010.
  111. Steensma DP, Sasu BJ, Sloan JA, Tomita DK, Loprinzi CL. Serum hepcidin levels predict response to intravenous iron and darbepoetin in chemotherapy-associated anemia. Blood. 2015 Jun 04; 125(23):3669-71. PMID: 26045598.
    View in: PubMed
  112. Kyle RA, Steensma DP, Shampo MA. Howard Walter Florey-Production of Penicillin. Mayo Clin Proc. 2015 Jun; 90(6):e63-4. PMID: 26046419.
    View in: PubMed
  113. Steensma DP, Bejar R, Jaiswal S, Lindsley RC, Sekeres MA, Hasserjian RP, Ebert BL. Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes. Blood. 2015 Jul 02; 126(1):9-16. PMID: 25931582; PMCID: PMC4624443.
  114. El-Jawahri AR, Abel GA, Steensma DP, LeBlanc TW, Fathi AT, Graubert TA, DeAngelo DJ, Wadleigh M, Ballen KK, Foster JE, Attar EC, Amrein PC, Brunner AM, Stone RM, Temel JS. Health care utilization and end-of-life care for older patients with acute myeloid leukemia. Cancer. 2015 Aug 15; 121(16):2840-8. PMID: 25926135; PMCID: PMC4418225.
  115. Shampo MA, Kyle RA, Steensma DP. John E. Walker—Nobel Prize in chemistry in 1997. Mayo Clin Proc. 2015 Apr; 90(4):e41. PMID: 25841265.
    View in: PubMed
  116. Steensma DP. Speaking a common language in MDS/MPNs. Blood. 2015 Mar 19; 125(12):1849-51. PMID: 25792730.
    View in: PubMed
  117. Padron E, Steensma DP. Cutting the cord from myelodysplastic syndromes: chronic myelomonocytic leukemia-specific biology and management strategies. Curr Opin Hematol. 2015 Mar; 22(2):163-70. PMID: 25575034.
    View in: PubMed
  118. Steensma DP. Mimicking MacGyver in the oncology clinic: improvisation and creative solutions, only rarely involving duct tape. J Natl Compr Canc Netw. 2015 Mar; 13(3):371-3. PMID: 25736013.
    View in: PubMed
  119. Sankaran VG, Ulirsch JC, Tchaikovskii V, Ludwig LS, Wakabayashi A, Kadirvel S, Lindsley RC, Bejar R, Shi J, Lovitch SB, Bishop DF, Steensma DP. X-linked macrocytic dyserythropoietic anemia in females with an ALAS2 mutation. J Clin Invest. 2015 Apr; 125(4):1665-9. PMID: 25705881; PMCID: PMC4396476.
  120. Brierley CK, Steensma DP. Thrombopoiesis-stimulating agents and myelodysplastic syndromes. Br J Haematol. 2015 May; 169(3):309-23. PMID: 25659186.
    View in: PubMed
  121. Kyle RA, Steensma DP, Shampo MA. Oscar (Oskar) Minkowski: discovery of the pancreatic origin of diabetes. Mayo Clin Proc. 2015 Feb; 90(2):e17-8. PMID: 25659250.
    View in: PubMed
  122. Lindsley RC, Mar BG, Mazzola E, Grauman PV, Shareef S, Allen SL, Pigneux A, Wetzler M, Stuart RK, Erba HP, Damon LE, Powell BL, Lindeman N, Steensma DP, Wadleigh M, DeAngelo DJ, Neuberg D, Stone RM, Ebert BL. Acute myeloid leukemia ontogeny is defined by distinct somatic mutations. Blood. 2015 Feb 26; 125(9):1367-76. PMID: 25550361; PMCID: PMC4342352.
  123. Roberts DA, Wadleigh M, McDonnell AM, DeAngelo DJ, Stone RM, Steensma DP. Low efficacy and high mortality associated with clofarabine treatment of relapsed/refractory acute myeloid leukemia and myelodysplastic syndromes. Leuk Res. 2015 Feb; 39(2):204-10. PMID: 25554239.
    View in: PubMed
  124. Jabbour EJ, Garcia-Manero G, Strati P, Mishra A, Al Ali NH, Padron E, Lancet J, Kadia T, Daver N, O'Brien S, Steensma DP, Sekeres MA, Gore SD, Dezern A, Roboz GJ, List AF, Kantarjian HM, Komrokji RS. Outcome of patients with low-risk and intermediate-1-risk myelodysplastic syndrome after hypomethylating agent failure: a report on behalf of the MDS Clinical Research Consortium. Cancer. 2015 Mar 15; 121(6):876-82. PMID: 25410759; PMCID: PMC4378905.
  125. Dumitrascu DL, Shampo M, Kyle RA, Steensma DP. Stamp vignette on medical science. Nicolae Testemitanu-Moldovan surgeon, scientist, and politician. Mayo Clin Proc. 2014 Dec; 89(12):e131. PMID: 25468521.
    View in: PubMed
  126. Steensma DP, Shampo MA, Kyle RA. Bruce Beutler: innate immunity and Toll-like receptors. Mayo Clin Proc. 2014 Oct; 89(10):e101. PMID: 25282435.
    View in: PubMed
  127. Bejar R, Steensma DP. Recent developments in myelodysplastic syndromes. Blood. 2014 Oct 30; 124(18):2793-803. PMID: 25237199.
    View in: PubMed
  128. Bejar R, Lord A, Stevenson K, Bar-Natan M, Pérez-Ladaga A, Zaneveld J, Wang H, Caughey B, Stojanov P, Getz G, Garcia-Manero G, Kantarjian H, Chen R, Stone RM, Neuberg D, Steensma DP, Ebert BL. TET2 mutations predict response to hypomethylating agents in myelodysplastic syndrome patients. Blood. 2014 Oct 23; 124(17):2705-12. PMID: 25224413; PMCID: PMC4208285.
  129. Freireich EJ, Wiernik PH, Steensma DP. The leukemias: a half-century of discovery. J Clin Oncol. 2014 Nov 01; 32(31):3463-9. PMID: 25185093.
    View in: PubMed
  130. Bejar R, Stevenson KE, Caughey B, Lindsley RC, Mar BG, Stojanov P, Getz G, Steensma DP, Ritz J, Soiffer R, Antin JH, Alyea E, Armand P, Ho V, Koreth J, Neuberg D, Cutler CS, Ebert BL. Somatic mutations predict poor outcome in patients with myelodysplastic syndrome after hematopoietic stem-cell transplantation. J Clin Oncol. 2014 Sep 01; 32(25):2691-8. PMID: 25092778; PMCID: PMC4207878.
  131. Steensma DP, Rayson D, Shampo MA, Kyle RA. Terry Fox: Canadian cancer research activist whose "Marathon of Hope" inspired millions. Mayo Clin Proc. 2014 Aug; 89(8):e75-6. PMID: 25092373.
    View in: PubMed
  132. Hasserjian RP, Campigotto F, Klepeis V, Fu B, Wang SA, Bueso-Ramos C, Cascio MJ, Rogers HJ, Hsi ED, Soderquist C, Bagg A, Yan J, Ochs R, Orazi A, Moore F, Mahmoud A, George TI, Foucar K, Odem J, Booth C, Morice W, DeAngelo DJ, Steensma D, Stone RM, Neuberg D, Arber DA. De novo acute myeloid leukemia with 20-29% blasts is less aggressive than acute myeloid leukemia with =30% blasts in older adults: a Bone Marrow Pathology Group study. Am J Hematol. 2014 Nov; 89(11):E193-9. PMID: 25042343.
    View in: PubMed
  133. Steensma DP, Kantarjian HM. Reply to J.S. Abrams et al. J Clin Oncol. 2014 Aug 10; 32(23):2516. PMID: 25002713.
    View in: PubMed
  134. Garcia-Manero G, Gartenberg G, Steensma DP, Schipperus MR, Breems DA, de Paz R, Valcárcel D, Kranenburg B, Reddy M, Komrokji RS. A phase 2, randomized, double-blind, multicenter study comparing siltuximab plus best supportive care (BSC) with placebo plus BSC in anemic patients with International Prognostic Scoring System low- or intermediate-1-risk myelodysplastic syndrome. Am J Hematol. 2014 Sep; 89(9):E156-62. PMID: 24888488.
    View in: PubMed
  135. Steensma DP, Montori VM, Shampo MA, Kyle RA. Stamp vignette on medical science. Daniel Alcides Carrión--Peruvian hero and medical martyr. Mayo Clin Proc. 2014 Jun; 89(6):e55-6. PMID: 24943706.
    View in: PubMed
  136. Kantarjian H, Steensma D, Rius Sanjuan J, Elshaug A, Light D. High cancer drug prices in the United States: reasons and proposed solutions. J Oncol Pract. 2014 Jul; 10(4):e208-11. PMID: 24803662.
    View in: PubMed
  137. Gafter-Gvili A, Steensma DP, Auerbach M. Should the ASCO/ASH Guidelines for the use of intravenous iron in cancer- and chemotherapy-induced anemia be updated? J Natl Compr Canc Netw. 2014 May; 12(5):657-64. PMID: 24812134.
    View in: PubMed
  138. Steensma DP, Shampo MA, Kyle RA. Physician-poet William Carlos Williams--"no ideas but in things". Mayo Clin Proc. 2014 Apr; 89(4):e35-6. PMID: 24684882.
    View in: PubMed
  139. Kantarjian HM, Steensma DP, Light DW. The Patient Protection and Affordable Care Act: Is it good or bad for oncology? Cancer. 2014 Jun 01; 120(11):1600-3. PMID: 24643748.
    View in: PubMed
  140. Steensma DP, Komrokji RS, Stone RM, List AF, Garcia-Manero G, Huber JM, Dennison B, Sekeres MA. Disparity in perceptions of disease characteristics, treatment effectiveness, and factors influencing treatment adherence between physicians and patients with myelodysplastic syndromes. Cancer. 2014 Jun 01; 120(11):1670-6. PMID: 24577838.
    View in: PubMed
  141. Adamia S, Bar-Natan M, Haibe-Kains B, Pilarski PM, Bach C, Pevzner S, Calimeri T, Avet-Loiseau H, Lode L, Verselis S, Fox EA, Galinsky I, Mathews S, Dagogo-Jack I, Wadleigh M, Steensma DP, Motyckova G, Deangelo DJ, Quackenbush J, Tenen DG, Stone RM, Griffin JD. NOTCH2 and FLT3 gene mis-splicings are common events in patients with acute myeloid leukemia (AML): new potential targets in AML. Blood. 2014 May 01; 123(18):2816-25. PMID: 24574459; PMCID: PMC4007608.
  142. Steensma DP, Shampo MA, Kyle RA. Wilberforce J. J. Arnold--"St. Helena's Greatest Friend". Mayo Clin Proc. 2014 Feb; 89(2):e15. PMID: 24485142.
    View in: PubMed
  143. Abel GA, Klaassen R, Lee SJ, Young NL, Cannella L, Steensma DP, Efficace F. Patient-reported outcomes for the myelodysplastic syndromes: a new MDS-specific measure of quality of life. Blood. 2014 Jan 16; 123(3):451-2. PMID: 24434998.
    View in: PubMed
  144. Steensma DP, Kantarjian HM. Impact of cancer research bureaucracy on innovation, costs, and patient care. J Clin Oncol. 2014 Feb 10; 32(5):376-8. PMID: 24395852.
    View in: PubMed
  145. McCarthy JT, Hocum CL, Albright RC, Rogers J, Gallaher EJ, Steensma DP, Gudgell SF, Bergstralh EJ, Dillon JC, Hickson LJ, Williams AW, Dingli D. Biomedical system dynamics to improve anemia control with darbepoetin alfa in long-term hemodialysis patients. Mayo Clin Proc. 2014 Jan; 89(1):87-94. PMID: 24388026.
    View in: PubMed
  146. Steensma DP, Shampo MA, Kyle RA. The 1964 "Doctors Mayo" commemorative postage stamp. Mayo Clin Proc. 2014 Jan; 89(1):e1-2. PMID: 24388034.
    View in: PubMed
  147. Kantarjian H, Steensma D, Light D. Should oncologists support the Affordable Care Act? Lancet Oncol. 2013 Dec; 14(13):1258-9. PMID: 24275127.
    View in: PubMed
  148. Shampo MA, Kyle RA, Steensma DP. Alois Alzheimer--Alzheimer disease. Mayo Clin Proc. 2013 Dec; 88(12):e155. PMID: 24290132.
    View in: PubMed
  149. Adamia S, Haibe-Kains B, Pilarski PM, Bar-Natan M, Pevzner S, Avet-Loiseau H, Lode L, Verselis S, Fox EA, Burke J, Galinsky I, Dagogo-Jack I, Wadleigh M, Steensma DP, Motyckova G, Deangelo DJ, Quackenbush J, Stone R, Griffin JD. A genome-wide aberrant RNA splicing in patients with acute myeloid leukemia identifies novel potential disease markers and therapeutic targets. Clin Cancer Res. 2014 Mar 01; 20(5):1135-45. PMID: 24284058; PMCID: PMC4458245.
  150. Bowen DT, Hellström-Lindberg E, Steensma DP. Cardiac iron overload assessed by T2* magnetic resonance imaging and cardiac function in regularly transfused myelodysplastic syndrome patients. Br J Haematol. 2014 Feb; 164(4):610-1. PMID: 24236802.
    View in: PubMed
  151. Shampo MA, Kyle RA, Steensma DP. James B. Collip--member of the Canadian team that isolated insulin. Mayo Clin Proc. 2013 Nov; 88(11):e139-40. PMID: 24182713.
    View in: PubMed
  152. Hartwell KA, Miller PG, Mukherjee S, Kahn AR, Stewart AL, Logan DJ, Negri JM, Duvet M, Järås M, Puram R, Dancik V, Al-Shahrour F, Kindler T, Tothova Z, Chattopadhyay S, Hasaka T, Narayan R, Dai M, Huang C, Shterental S, Chu LP, Haydu JE, Shieh JH, Steensma DP, Munoz B, Bittker JA, Shamji AF, Clemons PA, Tolliday NJ, Carpenter AE, Gilliland DG, Stern AM, Moore MAS, Scadden DT, Schreiber SL, Ebert BL, Golub TR. Niche-based screening identifies small-molecule inhibitors of leukemia stem cells. Nat Chem Biol. 2013 Dec; 9(12):840-848. PMID: 24161946; PMCID: PMC4009363.
  153. Steensma DP, Shampo MA, Kyle RA. Michael Servetus: unorthodox theologian, meticulous cartographer, and innovative anatomist. Mayo Clin Proc. 2013 Oct; 88(10):e119-20. PMID: 24079695.
    View in: PubMed
  154. Crawford J, Armitage J, Balducci L, Becker PS, Blayney DW, Cataland SR, Heaney ML, Hudock S, Kloth DD, Kuter DJ, Lyman GH, McMahon B, Rugo HS, Saad AA, Schwartzberg LS, Shayani S, Steensma DP, Talbott M, Vadhan-Raj S, Westervelt P, Westmoreland M, Dwyer M, Ho M. Myeloid growth factors. J Natl Compr Canc Netw. 2013 Oct 01; 11(10):1266-90. PMID: 24142827.
    View in: PubMed
  155. Steensma DP, Gattermann N. When is iron overload deleterious, and when and how should iron chelation therapy be administered in myelodysplastic syndromes? Best Pract Res Clin Haematol. 2013 Dec; 26(4):431-44. PMID: 24507819.
    View in: PubMed
  156. Ramsey H, Zhang Q, Brown DE, Steensma DP, Lin CP, Wu MX. Stress-induced hematopoietic failure in the absence of immediate early response gene X-1 (IEX-1, IER3). Haematologica. 2014 Feb; 99(2):282-91. PMID: 24056813; PMCID: PMC3912958.
  157. Shampo MA, Kyle RA, Steensma DP. Stamp vignette on medical science. Vincent du Vigneaud-Nobel Prize in chemistry. Mayo Clin Proc. 2013 Sep; 88(9):e99. PMID: 24001505.
    View in: PubMed
  158. Shampo MA, Kyle RA, Steensma DP. Tadeus Reichstein-work on hormones of the adrenal glands. Mayo Clin Proc. 2013 Aug; 88(8):e85. PMID: 23910422.
    View in: PubMed
  159. Shampo MA, Kyle RA, Steensma DP. John Robert Vane--British pharmacologist and Nobel laureate. Mayo Clin Proc. 2013 Jul; 88(7):e71. PMID: 23809324.
    View in: PubMed
  160. Attar EC, Amrein PC, Fraser JW, Fathi AT, McAfee S, Wadleigh M, Deangelo DJ, Steensma DP, Stone RM, Foster J, Neuberg D, Ballen KK. Phase I dose escalation study of bortezomib in combination with lenalidomide in patients with myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML). Leuk Res. 2013 Sep; 37(9):1016-20. PMID: 23773898; PMCID: PMC3969839.
  161. Sherman AE, Motyckova G, Fega KR, Deangelo DJ, Abel GA, Steensma D, Wadleigh M, Stone RM, Driver JA. Geriatric assessment in older patients with acute myeloid leukemia: a retrospective study of associated treatment and outcomes. Leuk Res. 2013 Sep; 37(9):998-1003. PMID: 23747082; PMCID: PMC3735611.
  162. Shampo MA, Kyle RA, Steensma DP. Jens Skou--nobel prize in chemistry. Mayo Clin Proc. 2013 Jun; 88(6):e55. PMID: 23726407.
    View in: PubMed
  163. Steensma DP, Ebert BL. Initial experience with L-leucine therapy in myelodysplastic syndromes with associated chromosome 5q deletion. Blood. 2013 May 23; 121(21):4428. PMID: 23704049.
    View in: PubMed
  164. Steensma DP, Sekeres MA. Reply to H. Kantarjian et al. J Clin Oncol. 2013 May 10; 31(14):1796. PMID: 23802242.
    View in: PubMed
  165. Shampo MA, Kyle RA, Steensma DP. Ian Wilmut--pioneer of cloning. Mayo Clin Proc. 2013 May; 88(5):e41. PMID: 23639503.
    View in: PubMed
  166. Steensma DP. The beginning of the end of the beginning in cancer genomics. N Engl J Med. 2013 May 30; 368(22):2138-40. PMID: 23634995.
    View in: PubMed
  167. Shampo MA, Kyle RA, Steensma DP. Horace Magoun--neuroanatomist and neurophysiologist. Mayo Clin Proc. 2013 Apr; 88(4):e33. PMID: 23541022.
    View in: PubMed
  168. Shampo MA, Kyle RA, Steensma DP. Hermann staudinger-founder of polymer chemistry. Mayo Clin Proc. 2013 Mar; 88(3):e23. PMID: 23489462.
    View in: PubMed
  169. Tothova Z, Steensma DP, Ebert BL. New strategies in myelodysplastic syndromes: application of molecular diagnostics to clinical practice. Clin Cancer Res. 2013 Apr 01; 19(7):1637-43. PMID: 23329810; PMCID: PMC3748432.
  170. Shampo MA, Kyle RA, Steensma DP. Elias James Corey--Nobel Prize for retrosynthetic analysis. Mayo Clin Proc. 2013 Jan; 88(1):e7. PMID: 23274030.
    View in: PubMed
  171. Steensma DP. Stories we tell one another: narrative reflection and the art of oncology. Am Soc Clin Oncol Educ Book. 2013. PMID: 23714539.
    View in: PubMed
  172. Shampo MA, Kyle RA, Steensma DP. Richard Ernst--Nobel Prize for nuclear magnetic resonance spectroscopy. Mayo Clin Proc. 2012 Dec; 87(12):e109. PMID: 23218094; PMCID: PMC3547585.
  173. Steensma DP. Dysplasia has A differential diagnosis: distinguishing genuine myelodysplastic syndromes (MDS) from mimics, imitators, copycats and impostors. Curr Hematol Malig Rep. 2012 Dec; 7(4):310-20. PMID: 23015360.
    View in: PubMed
  174. Steensma DP, Viprakasit V, Kyle RA, Shampo MA. Prince Wongsa Dhiraj Snid--Thai physician and diplomat. Mayo Clin Proc. 2012 Nov; 87(11):e93. PMID: 23127744; PMCID: PMC3532691.
  175. Brierley CK, Morgan EA, Sprague JR, Odejide OO, DeAngelo DJ, Steensma DP. An extreme example of focal bone marrow involvement in acute myeloid leukemia. Am J Hematol. 2013 Apr; 88(4):335-6. PMID: 23115117.
    View in: PubMed
  176. Steensma DP. Can hypomethylating agents provide a platform for curative therapy in myelodysplastic syndromes? Best Pract Res Clin Haematol. 2012 Dec; 25(4):443-51. PMID: 23200541.
    View in: PubMed
  177. Shampo MA, Kyle RA, Steensma DP. Sidney Altman--Nobel laureate for work with RNA. Mayo Clin Proc. 2012 Oct; 87(10):e73. PMID: 23036683; PMCID: PMC3498233.
  178. Sekeres MA, Steensma DP. Boulevard of broken dreams: drug approval for older adults with acute myeloid leukemia. J Clin Oncol. 2012 Nov 20; 30(33):4061-3. PMID: 23008302.
    View in: PubMed
  179. Kyle RA, Shampo MA, Steensma DP. Sir Brian Gerald Barratt-Boyes-pioneer cardiac surgeon. Mayo Clin Proc. 2012 Sep; 87(9):e65. PMID: 22959001; PMCID: PMC3498336.
  180. Steensma DP. Historical perspectives on myelodysplastic syndromes. Leuk Res. 2012 Dec; 36(12):1441-52. PMID: 22921019.
    View in: PubMed
  181. Bejar R, Stevenson KE, Caughey BA, Abdel-Wahab O, Steensma DP, Galili N, Raza A, Kantarjian H, Levine RL, Neuberg D, Garcia-Manero G, Ebert BL. Validation of a prognostic model and the impact of mutations in patients with lower-risk myelodysplastic syndromes. J Clin Oncol. 2012 Sep 20; 30(27):3376-82. PMID: 22869879; PMCID: PMC3438234.
  182. Shampo MA, Kyle RA, Steensma DP. Catherine Verfaillie--stem cell researcher. Mayo Clin Proc. 2012 Aug; 87(8):e59. PMID: 22862876; PMCID: PMC3498419.
  183. Ruiz-Argüelles GJ, Gomez-Almaguer D, Steensma DP. Outdated dogma? Busulfan, seizure prophylaxis, and stem cell allografting. Am J Hematol. 2012 Sep; 87(9):941. PMID: 22674687.
    View in: PubMed
  184. Shampo MA, Kyle RA, Steensma DP. William Shockley and the transistor. Mayo Clin Proc. 2012 Jun; 87(6):e43. PMID: 22677083; PMCID: PMC3498287.
  185. Steensma DP. Tuning the rigging before sailing off into the stormy sea of stem cell transplants for patients with myelodysplastic syndromes. Biol Blood Marrow Transplant. 2012 Aug; 18(8):1145-7. PMID: 22609039.
    View in: PubMed
  186. Shampo MA, Kyle RA, Steensma DP. Charles F. Kettering-medical philanthropist and inventor. Mayo Clin Proc. 2012 May; 87(5):e35. PMID: 22560533; PMCID: PMC3498412.
  187. List AF, Baer MR, Steensma DP, Raza A, Esposito J, Martinez-Lopez N, Paley C, Feigert J, Besa E. Deferasirox reduces serum ferritin and labile plasma iron in RBC transfusion-dependent patients with myelodysplastic syndrome. J Clin Oncol. 2012 Jun 10; 30(17):2134-9. PMID: 22547607.
    View in: PubMed
  188. Raza A, Galili N, Mulford D, Smith SE, Brown GL, Steensma DP, Lyons RM, Boccia R, Sekeres MA, Garcia-Manero G, Mesa RA. Phase 1 dose-ranging study of ezatiostat hydrochloride in combination with lenalidomide in patients with non-deletion (5q) low to intermediate-1 risk myelodysplastic syndrome (MDS). J Hematol Oncol. 2012 Apr 30; 5:18. PMID: 22546242; PMCID: PMC3416694.
  189. Shampo MA, Kyle RA, Steensma DP. Adolf Butenandt--Nobel Prize for chemistry. Mayo Clin Proc. 2012 Apr; 87(4):e27. PMID: 22469359; PMCID: PMC3498200.
  190. Jacobsen PB, Holland JC, Steensma DP. Caring for the whole patient: the science of psychosocial care. J Clin Oncol. 2012 Apr 10; 30(11):1151-3. PMID: 22412125.
    View in: PubMed
  191. Motyckova G, Steensma DP. Why does my patient have lymphadenopathy or splenomegaly? Hematol Oncol Clin North Am. 2012 Apr; 26(2):395-408, ix. PMID: 22463834.
    View in: PubMed
  192. Shampo MA, Kyle RA, Steensma DP. Alexander Todd--British Nobel laureate. Mayo Clin Proc. 2012 Mar; 87(3):e19. PMID: 22386189; PMCID: PMC3498063.
  193. Shampo MA, Kyle RA, Steensma DP. Isidor Rabi-1944 Nobel laureate in physics. Mayo Clin Proc. 2012 Feb; 87(2):e11. PMID: 22305037; PMCID: PMC3498002.
  194. Costanzi C, Bourdette D, Parisi JE, Woltjer R, Rodriguez F, Steensma D, Lucchinetti CF. Crystal-storing histiocytosis: An unusual relapsing inflammatory CNS disorder. Mult Scler Relat Disord. 2012 Apr; 1(2):95-9. PMID: 25876937; PMCID: PMC4612576.
  195. Shampo MA, Kyle RA, Steensma DP. Nikolay Basov--nobel prize for lasers and masers. Mayo Clin Proc. 2012 Jan; 87(1):e3. PMID: 22212977; PMCID: PMC3498096.
  196. Steensma DP. Oddballs: acute leukemias of mixed phenotype and ambiguous origin. Hematol Oncol Clin North Am. 2011 Dec; 25(6):1235-53. PMID: 22093585.
    View in: PubMed
  197. Shampo MA, Kyle RA, Steensma DP. Hans Geiger-German physicist and the Geiger counter. Mayo Clin Proc. 2011 Dec; 86(12):e54. PMID: 22196280; PMCID: PMC3228631.
  198. Patnaik MM, Lasho TL, Hodnefield JM, Knudson RA, Ketterling RP, Garcia-Manero G, Steensma DP, Pardanani A, Hanson CA, Tefferi A. SF3B1 mutations are prevalent in myelodysplastic syndromes with ring sideroblasts but do not hold independent prognostic value. Blood. 2012 Jan 12; 119(2):569-72. PMID: 22096241; PMCID: PMC4916563.
  199. Shampo MA, Kyle RA, Steensma DP. Paul D. Boyer—Nobel prize for work on ATP synthase. Mayo Clin Proc. 2011 Nov; 86(11):e51. PMID: 22141183; PMCID: PMC3203009.
  200. Shampo MA, Kyle RA, Steensma DP. Walter Hess—Nobel Prize for work on the brain. Mayo Clin Proc. 2011 Oct; 86(10):E49. PMID: 22069789; PMCID: PMC3184029.
  201. Steensma DP. Hematopoietic growth factors in myelodysplastic syndromes. Semin Oncol. 2011 Oct; 38(5):635-47. PMID: 21943670.
    View in: PubMed
  202. Shampo MA, Kyle RA, Steensma DP. Charles Townes—nobel laureate for maser-laser work. Mayo Clin Proc. 2011 Sep; 86(9):e48. PMID: 21984996; PMCID: PMC3257993.
  203. Sekeres MA, Steensma DP. A piece of my mind. The road warriors. JAMA. 2011 Aug 24; 306(8):805-6. PMID: 21862735.
    View in: PubMed
  204. Shampo MA, Kyle RA, Steensma DP. Charles K. Kao—father of fiber optics. Mayo Clin Proc. 2011 Aug; 86(8):e45. PMID: 21919227; PMCID: PMC3146387.
  205. Crawford J, Allen J, Armitage J, Blayney DW, Cataland SR, Heaney ML, Htoy S, Hudock S, Kloth DD, Kuter DJ, Lyman GH, McMahon B, Steensma DP, Vadhan-Raj S, Westervelt P, Westmoreland M. Myeloid growth factors. J Natl Compr Canc Netw. 2011 Aug 01; 9(8):914-32. PMID: 21900221.
    View in: PubMed
  206. Kaufmann SH, Karp JE, Litzow MR, Mesa RA, Hogan W, Steensma DP, Flatten KS, Loegering DA, Schneider PA, Peterson KL, Maurer MJ, Smith BD, Greer J, Chen Y, Reid JM, Ivy SP, Ames MM, Adjei AA, Erlichman C, Karnitz LM. Phase I and pharmacological study of cytarabine and tanespimycin in relapsed and refractory acute leukemia. Haematologica. 2011 Nov; 96(11):1619-26. PMID: 21791475; PMCID: PMC3208679.
  207. Steensma DP. Art of oncology: new voices wanted. J Clin Oncol. 2011 Sep 01; 29(25):3343-4. PMID: 21788569.
    View in: PubMed
  208. Steensma DP, Stone RM. Lenalidomide in AML: del(5q) or who? Blood. 2011 Jul 21; 118(3):481-2. PMID: 21778344.
    View in: PubMed
  209. Shampo MA, Kyle RA, Steensma DP. Albert Sabin--conqueror of poliomyelitis. Mayo Clin Proc. 2011 Jul; 86(7):e44. PMID: 21719614; PMCID: PMC3127575.
  210. Shampo MA, Kyle RA, Steensma DP. Frederick Soddy--pioneer in radioactivity. Mayo Clin Proc. 2011 Jun; 86(6):e39. PMID: 21780319; PMCID: PMC3104923.
  211. Steensma DP. The relevance of iron overload and the appropriateness of iron chelation therapy for patients with myelodysplastic syndromes: a dialogue and debate. Curr Hematol Malig Rep. 2011 Jun; 6(2):136-44. PMID: 21373838.
    View in: PubMed
  212. Steensma DP, Sasu BJ, Sloan JA, Tomita D, Loprinzi CL. The relationship between serum hepcidin levels and clinical outcomes in patients with chemotherapy-associated anemia treated in a controlled trial. J Clin Oncol. 2011 May 20; 29(15_suppl):9031. PMID: 28021663.
    View in: PubMed
  213. Shampo MA, Kyle RA, Steensma DP. Aleksandr Prokhorov--lasers and masers. Mayo Clin Proc. 2011 May; 86(5):e33. PMID: 21688406; PMCID: PMC3084655.
  214. Sekeres MA, Maciejewski JP, List AF, Steensma DP, Artz A, Swern AS, Scribner P, Huber J, Stone R. Perceptions of disease state, treatment outcomes, and prognosis among patients with myelodysplastic syndromes: results from an internet-based survey. Oncologist. 2011; 16(6):904-11. PMID: 21478277; PMCID: PMC3228221.
  215. Baumann Kreuziger LM, Wolanskyj AP, Hanson CA, Steensma DP. Lack of efficacy of pyridoxine (vitamin B6) treatment in acquired idiopathic sideroblastic anaemia, including refractory anaemia with ring sideroblasts. Eur J Haematol. 2011 Jun; 86(6):512-6. PMID: 21388451.
    View in: PubMed
  216. Shampo MA, Kyle RA, Steensma DP. Susumu Tonegawa--Japan's first Nobel laureate in physiology or medicine. Mayo Clin Proc. 2011 Feb; 86(2):e14. PMID: 21282480; PMCID: PMC3031445.
  217. Thapaliya P, Tefferi A, Pardanani A, Steensma DP, Camoriano J, Wu W, Geyer S, Mesa RA. International working group for myelofibrosis research and treatment response assessment and long-term follow-up of 50 myelofibrosis patients treated with thalidomide-prednisone based regimens. Am J Hematol. 2011 Jan; 86(1):96-8. PMID: 21132732.
    View in: PubMed
  218. Kyle RA, Steensma DP. History of multiple myeloma. Recent Results Cancer Res. 2011; 183:3-23. PMID: 21509678.
    View in: PubMed
  219. Steensma DP. The role of iron chelation therapy for patients with myelodysplastic syndromes. J Natl Compr Canc Netw. 2011 Jan; 9(1):65-75. PMID: 21233245.
    View in: PubMed
  220. Steensma DP, Sloan JA, Dakhil SR, Dalton R, Kahanic SP, Prager DJ, Stella PJ, Rowland KM, Novotny PJ, Loprinzi CL. Phase III, randomized study of the effects of parenteral iron, oral iron, or no iron supplementation on the erythropoietic response to darbepoetin alfa for patients with chemotherapy-associated anemia. J Clin Oncol. 2011 Jan 01; 29(1):97-105. PMID: 21098317; PMCID: PMC3055863.
  221. Steensma DP, Kyle RA, Shampo MA. Abbie Lathrop, the "mouse woman of Granby": rodent fancier and accidental genetics pioneer. Mayo Clin Proc. 2010 Nov; 85(11):e83. PMID: 21061734; PMCID: PMC2966381.
  222. Loprinzi CL, Schapira L, Moynihan T, Kalemkerian GP, von Gunten C, Steensma D. Compassionate honesty. J Palliat Med. 2010 Oct; 13(10):1187-91. PMID: 20846004.
    View in: PubMed
  223. Steensma DP, Kyle RA, Shampo MA. Walter Clement Noel—first patient described with sickle cell disease. Mayo Clin Proc. 2010 Oct; 85(10):e74-5. PMID: 20931692; PMCID: PMC2947974.
  224. Davids MS, Steensma DP. The molecular pathogenesis of myelodysplastic syndromes. Cancer Biol Ther. 2010 Aug 15; 10(4):309-19. PMID: 20592488.
    View in: PubMed
  225. Steensma DP. The scent of cancer. Ann Intern Med. 2010 Aug 03; 153(3):206-7. PMID: 20679566.
    View in: PubMed
  226. Shampo MA, Kyle RA, Steensma DP. Stamp vignette on medical science. Robert F. Curl Jr-Nobel Laureate in Chemistry. Mayo Clin Proc. 2010 Aug; 85(8):e58. PMID: 20704028; PMCID: PMC2912751.
  227. Steensma DP. A cello for Michayla. J Clin Oncol. 2010 Oct 01; 28(28):4400-1. PMID: 20660826.
    View in: PubMed
  228. Shampo MA, Kyle RA, Steensma DP. Edward L. Trudeau--founder of a sanatorium for treatment of tuberculosis. Mayo Clin Proc. 2010 Jul; 85(7):e48. PMID: 20592164; PMCID: PMC2894729.
  229. Steensma DP. P39/Tsugane cells are a false cell line contaminated with HL-60 cells and are not suitable for mechanistic studies in myelodysplastic syndromes. Haematologica. 2010 Jul; 95(7):1229-30. PMID: 20421273; PMCID: PMC2895053.
  230. Steensma DP. Novel therapies for myelodysplastic syndromes. Hematol Oncol Clin North Am. 2010 Apr; 24(2):423-41. PMID: 20359635.
    View in: PubMed
  231. Calvin AD, Somers VK, Steensma DP, Rio Perez JA, van der Walt C, Fitz-Gibbon JM, Scott CG, Olson LJ. Advanced heart failure and nocturnal hypoxaemia due to central sleep apnoea are associated with increased serum erythropoietin. Eur J Heart Fail. 2010 Apr; 12(4):354-9. PMID: 20335353; PMCID: PMC2844758.
  232. Steensma DP, Stone RM. Practical recommendations for hypomethylating agent therapy of patients with myelodysplastic syndromes. Hematol Oncol Clin North Am. 2010 Apr; 24(2):389-406. PMID: 20359633.
    View in: PubMed
  233. Jacobs NL, Holtan SG, Porrata LF, Markovic SN, Tefferi A, Steensma DP. Host immunity affects survival in myelodysplastic syndromes: Independent prognostic value of the absolute lymphocyte count. Am J Hematol. 2010 Mar; 85(3):160-3. PMID: 20131304.
    View in: PubMed
  234. Steensma DP. ACP Journal Club. Anemia was independently associated with mortality in very old persons. Ann Intern Med. 2009 Dec 15; 151(12):JC6-13. PMID: 20008749.
    View in: PubMed
  235. Steensma DP. Decitabine treatment of patients with higher-risk myelodysplastic syndromes. Leuk Res. 2009 Dec; 33 Suppl 2:S12-7. PMID: 20004791.
    View in: PubMed
  236. Savica R, Grossardt BR, Carlin JM, Icen M, Bower JH, Ahlskog JE, Maraganore DM, Steensma DP, Rocca WA. Anemia or low hemoglobin levels preceding Parkinson disease: a case-control study. Neurology. 2009 Oct 27; 73(17):1381-7. PMID: 19858460; PMCID: PMC2769554.
  237. Steensma DP, Neiger JD, Porcher JC, Keats JJ, Bergsagel PL, Dennis TR, Knudson RA, Jenkins RB, Santana-Davila R, Kumar R, Ketterling RP. Rearrangements and amplification of IER3 (IEX-1) represent a novel and recurrent molecular abnormality in myelodysplastic syndromes. Cancer Res. 2009 Oct 01; 69(19):7518-23. PMID: 19773435; PMCID: PMC3157243.
  238. Steensma DP. Out of this nettle, danger, we must pluck this flower, safety. Blood. 2009 Sep 17; 114(12):2364-5. PMID: 19762499.
    View in: PubMed
  239. Sekeres MA, Steensma DP. Defining prior therapy in myelodysplastic syndromes and criteria for relapsed and refractory disease: implications for clinical trial design and enrollment. Blood. 2009 Sep 24; 114(13):2575-80. PMID: 19605847; PMCID: PMC2756119.
  240. Bohlius J, Schmidlin K, Brillant C, Schwarzer G, Trelle S, Seidenfeld J, Zwahlen M, Clarke MJ, Weingart O, Kluge S, Piper M, Napoli M, Rades D, Steensma D, Djulbegovic B, Fey MF, Ray-Coquard I, Moebus V, Thomas G, Untch M, Schumacher M, Egger M, Engert A. Erythropoietin or Darbepoetin for patients with cancer--meta-analysis based on individual patient data. Cochrane Database Syst Rev. 2009 Jul 08; (3):CD007303. PMID: 19588423.
    View in: PubMed
  241. Steensma DP, Baer MR, Slack JL, Buckstein R, Godley LA, Garcia-Manero G, Albitar M, Larsen JS, Arora S, Cullen MT, Kantarjian H. Multicenter study of decitabine administered daily for 5 days every 4 weeks to adults with myelodysplastic syndromes: the alternative dosing for outpatient treatment (ADOPT) trial. J Clin Oncol. 2009 Aug 10; 27(23):3842-8. PMID: 19528372; PMCID: PMC4879689.
  242. Steensma D, Kantarjian H, Wijermans P. Clinical experience with different dosing schedules of decitabine in patients with myelodysplastic syndromes (MDS). J Clin Oncol. 2009 May 20; 27(15_suppl):7011. PMID: 27961372.
    View in: PubMed
  243. Bohlius J, Schmidlin K, Brillant C, Schwarzer G, Trelle S, Seidenfeld J, Zwahlen M, Clarke M, Weingart O, Kluge S, Piper M, Rades D, Steensma DP, Djulbegovic B, Fey MF, Ray-Coquard I, Machtay M, Moebus V, Thomas G, Untch M, Schumacher M, Egger M, Engert A. Recombinant human erythropoiesis-stimulating agents and mortality in patients with cancer: a meta-analysis of randomised trials. Lancet. 2009 May 02; 373(9674):1532-42. PMID: 19410717.
    View in: PubMed
  244. Tefferi A, Mesa RA, Pardanani A, Hussein K, Schwager S, Hanson CA, Steensma DP. Red blood cell transfusion need at diagnosis adversely affects survival in primary myelofibrosis-increased serum ferritin or transfusion load does not. Am J Hematol. 2009 May; 84(5):265-7. PMID: 19396855.
    View in: PubMed
  245. Steensma DP. The Blood of the Lamb. J Clin Oncol. 2009 Jun 01; 27(16):2729-31. PMID: 19380440.
    View in: PubMed
  246. Steensma DP. The ordinary miracle of cancer clinical trials. J Clin Oncol. 2009 Apr 10; 27(11):1737-9. PMID: 19255310.
    View in: PubMed
  247. Mesa RA, Schwager S, Radia D, Cheville A, Hussein K, Niblack J, Pardanani AD, Steensma DP, Litzow MR, Rivera CE, Camoriano J, Verstovsek S, Sloan J, Harrison C, Kantarjian H, Tefferi A. The Myelofibrosis Symptom Assessment Form (MFSAF): an evidence-based brief inventory to measure quality of life and symptomatic response to treatment in myelofibrosis. Leuk Res. 2009 Sep; 33(9):1199-203. PMID: 19250674; PMCID: PMC4419687.
  248. Steensma DP, Porcher JC, Litzow MR, Hogan WJ, Arora S, Van Laar ES. Assessment of ATRX expression in patients with myelodysplastic syndromes treated with decitabine. Leuk Res. 2009 Jul; 33(7):e81-2. PMID: 19157545; PMCID: PMC2730658.
  249. Li C, Di Pierro E, Brancaleoni V, Cappellini MD, Steensma DP. A novel large deletion and three polymorphisms in the FECH gene associated with erythropoietic protoporphyria. Clin Chem Lab Med. 2009; 47(1):44-6. PMID: 19055472.
    View in: PubMed
  250. Steensma DP. The changing classification of myelodysplastic syndromes: what's in a name? Hematology Am Soc Hematol Educ Program. 2009; 645-55. PMID: 20008250.
    View in: PubMed
  251. Steensma DP. Erythropoiesis-stimulating agents are effective in myelodysplastic syndromes, but are they safe? Am J Hematol. 2009 Jan; 84(1):3-5. PMID: 19037863.
    View in: PubMed
  252. Wardrop D, Steensma DP. Is refractory anaemia with ring sideroblasts and thrombocytosis (RARS-T) a necessary or useful diagnostic category? Br J Haematol. 2009 Mar; 144(6):809-17. PMID: 19120370.
    View in: PubMed
  253. Steensma DP. Myelodysplasia paranoia: iron as the new radon. Leuk Res. 2009 Sep; 33(9):1158-63. PMID: 19036443.
    View in: PubMed
  254. Steensma DP, Tefferi A. Incremental gains and a long road ahead in MDS. Oncology (Williston Park). 2008 Nov 15; 22(12):1352, 1358, 1360. PMID: 19320067.
    View in: PubMed
  255. Kumar N, Sandroni P, Steensma DP, Luthra HS, Habermann TM. Polyradiculopathy due to methotrexate-induced ebv-associated lymphoproliferative disorder. Neurology. 2008 Nov 11; 71(20):1644-5. PMID: 19001256.
    View in: PubMed
  256. Knoll BM, Letendre L, Steensma DP. Life-threatening desquamating rash and hyperammonemia following administration of eculizumab for paroxysmal nocturnal hemoglobinuria. Am J Hematol. 2008 Nov; 83(11):881-3. PMID: 18756538.
    View in: PubMed
  257. Steensma DP, Shampo MA, Kyle RA. George Herman "Babe" Ruth Jr: baseball star and early participant in a cancer clinical trial. Mayo Clin Proc. 2008 Nov; 83(11):1262. PMID: 19004136.
    View in: PubMed
  258. Chen D, Hoyer JD, Ketterling RP, Tefferi A, Steensma DP, Holtan SG, Santana-Davila R, Porrata LF, Dewald GW, Hanson CA. Dysgranulopoiesis is an independent adverse prognostic factor in chronic myeloid disorders with an isolated interstitial deletion of chromosome 5q. Leukemia. 2009 Apr; 23(4):796-800. PMID: 18946493.
    View in: PubMed
  259. Baumann Kreuziger LM, Steensma DP. RAD51 and XRCC3 polymorphism frequency and risk of myelodysplastic syndromes. Am J Hematol. 2008 Oct; 83(10):822-3. PMID: 18756535; PMCID: PMC2768490.
  260. Steensma DP. Prospects and perils of retrospective risk assessment of erythropoiesis-stimulating agents. Am J Hematol. 2008 Sep; 83(9):693-4. PMID: 18615451.
    View in: PubMed
  261. Holtan SG, Santana-Davila R, Dewald GW, Khetterling RP, Knudson RA, Hoyer JD, Chen D, Hanson CA, Porrata L, Tefferi A, Steensma DP. Myelodysplastic syndromes associated with interstitial deletion of chromosome 5q: clinicopathologic correlations and new insights from the pre-lenalidomide era. Am J Hematol. 2008 Sep; 83(9):708-13. PMID: 18634051.
    View in: PubMed
  262. Caudill JS, Imran H, Porcher JC, Steensma DP. Congenital sideroblastic anemia associated with germline polymorphisms reducing expression of FECH. Haematologica. 2008 Oct; 93(10):1582-4. PMID: 18698088.
    View in: PubMed
  263. Gangat N, Porcher JC, Steensma DP. Absence of frataxin mutations in refractory anemia with ring sideroblasts (RARS). Leuk Res. 2009 Apr; 33(4):586-7. PMID: 18687468.
    View in: PubMed
  264. Chee CE, Steensma DP, Wu W, Hanson CA, Tefferi A. Neither serum ferritin nor the number of red blood cell transfusions affect overall survival in refractory anemia with ringed sideroblasts. Am J Hematol. 2008 Aug; 83(8):611-3. PMID: 18442062.
    View in: PubMed
  265. Dronca RS, Steensma DP. VTE and mortality associated with erythropoiesis-stimulating agents in cancer-associated anemia. Nat Clin Pract Oncol. 2008 Sep; 5(9):504-5. PMID: 18648351.
    View in: PubMed
  266. Steensma DP. The mosaic of myeloid neoplasia: implications for classification. Leuk Lymphoma. 2008 Jul; 49(7):1228-9. PMID: 18604710.
    View in: PubMed
  267. Steensma DP. The art of oncology: when the tumor is not the target. Don't mention it. J Clin Oncol. 2008 Jun 20; 26(18):3083-4. PMID: 18565895.
    View in: PubMed
  268. Steensma DP. Review: epoetin and darbepoetin reduce need for blood transfusions but increase risk for thrombosis in patients with cancer. ACP J Club. 2008 Jun 17; 148(4):7. PMID: 18588258.
    View in: PubMed
  269. Santana-Davila R, Tefferi A, Holtan SG, Ketterling RP, Dewald GW, Knudson RA, Steensma DP, Chen D, Hoyer JD, Hanson CA. Primary myelofibrosis is the most frequent myeloproliferative neoplasm associated with del(5q): clinicopathologic comparison of del(5q)-positive and -negative cases. Leuk Res. 2008 Dec; 32(12):1927-30. PMID: 18538839.
    View in: PubMed
  270. Gibbons RJ, Wada T, Fisher CA, Malik N, Mitson MJ, Steensma DP, Fryer A, Goudie DR, Krantz ID, Traeger-Synodinos J. Mutations in the chromatin-associated protein ATRX. Hum Mutat. 2008 Jun; 29(6):796-802. PMID: 18409179.
    View in: PubMed
  271. Steensma DP, Baer MR, Slack JL, Buckstein R, Godley LA, Larsen JS, Arora S, Cullen MT, Kantarjian HM. A multicenter phase II trial of the decitabine alternative 5-day dosing regimen: Analysis of efficacy in various subgroups of patients with myelodysplastic syndromes (MDS). J Clin Oncol. 2008 May 20; 26(15_suppl):7032. PMID: 27950008.
    View in: PubMed
  272. Godley LA, Steensma DP, Baer MR, Slack JL, Buckstein R, Larsen JS, Arora S, Cullen MT, Kantarjian HM. Cytogenetic responses to a 5-day dosing schedule of decitabine in patients (Pts) with myelodysplastic syndromes (MDS). J Clin Oncol. 2008 May 20; 26(15_suppl):7030. PMID: 27950013.
    View in: PubMed
  273. Caudill JS, Porcher JC, Steensma DP. Aberrant pre-mRNA splicing of a highly conserved cell cycle regulator, CDC25C, in myelodysplastic syndromes. Leuk Lymphoma. 2008 May; 49(5):989-93. PMID: 18464119.
    View in: PubMed
  274. Steensma DP. Investment analysts and the American Society of Hematology. Blood. 2008 Jul 01; 112(1):29-33. PMID: 18381975.
    View in: PubMed
  275. Steensma DP. A premature obituary for erythropoietin analogues. Lancet Oncol. 2008 Apr; 9(4):316. PMID: 18374288.
    View in: PubMed
  276. Hanson CA, Steensma DP, Hodnefield JM, Nguyen PL, Hoyer JD, Viswanatha DS, Zou Y, Knudson RA, Van Dyke DL, Ketterling RP. Isolated trisomy 15: a clonal chromosome abnormality in bone marrow with doubtful hematologic significance. Am J Clin Pathol. 2008 Mar; 129(3):478-85. PMID: 18285273.
    View in: PubMed
  277. Steensma DP, Tefferi A. JAK2 V617F and ringed sideroblasts: not necessarily RARS-T. Blood. 2008 Feb 01; 111(3):1748. PMID: 18223181.
    View in: PubMed
  278. Palmer SR, Tefferi A, Hanson CA, Steensma DP. Platelet count is an IPSS-independent risk factor predicting survival in refractory anaemia with ringed sideroblasts. Br J Haematol. 2008 Mar; 140(6):722-5. PMID: 18241255.
    View in: PubMed
  279. Steensma DP. Is anemia of cancer different from chemotherapy-induced anemia? J Clin Oncol. 2008 Mar 01; 26(7):1022-4. PMID: 18227523.
    View in: PubMed
  280. Steensma DP, Heptinstall KV, Johnson VM, Novotny PJ, Sloan JA, Camoriano JK, Niblack J, Bennett JM, Mesa RA. Common troublesome symptoms and their impact on quality of life in patients with myelodysplastic syndromes (MDS): results of a large internet-based survey. Leuk Res. 2008 May; 32(5):691-8. PMID: 18054795.
    View in: PubMed
  281. Steensma DP. New ASH/ASCO guidelines on the use of erythropoiesis-stimulating agents: a chorale amid cacophony. J Support Oncol. 2007 Nov-Dec; 5(10):471-3. PMID: 18240668.
    View in: PubMed
  282. Steensma DP, Porcher JC, Hanson CA, Lathrop CL, Hoyer JD, Lasho TA, Tefferi A, Higgs DR. Prevalence of erythrocyte haemoglobin H inclusions in unselected patients with clonal myeloid disorders. Br J Haematol. 2007 Nov; 139(3):439-42. PMID: 17910635.
    View in: PubMed
  283. Steensma DP. Exacerbation of asthma by Florida "red tide" during an ocean sailing trip. Mayo Clin Proc. 2007 Sep; 82(9):1128-30. PMID: 17803882.
    View in: PubMed
  284. White JG, Nichols WL, Steensma DP. Platelet pathology in sex-linked GATA-1 dyserythropoietic macrothrombocytopenia II. Cytochemistry. Platelets. 2007 Sep; 18(6):436-50. PMID: 17763153.
    View in: PubMed
  285. Santana-Davila R, Holtan SG, Dewald GW, Ketterling RP, Knudson RA, Hanson CA, Steensma DP, Tefferi A. Chromosome 5q deletion: specific diagnoses and cytogenetic details among 358 consecutive cases from a single institution. Leuk Res. 2008 Mar; 32(3):407-11. PMID: 17707907.
    View in: PubMed
  286. Steensma DP, Friday BB. Monocytic skin nodules in chronic myelomonocytic leukemia: clinical response to decitabine therapy. Leuk Lymphoma. 2007 Aug; 48(8):1628-9. PMID: 17701595.
    View in: PubMed
  287. Steensma DP, Tefferi A. Anemia in the elderly: how should we define it, when does it matter, and what can be done? Mayo Clin Proc. 2007 Aug; 82(8):958-66. PMID: 17673065.
    View in: PubMed
  288. Steensma DP. The spectrum of molecular aberrations in myelodysplastic syndromes: in the shadow of acute myeloid leukemia. Haematologica. 2007 Jun; 92(6):723-7. PMID: 17550842.
    View in: PubMed
  289. White JG, Nichols WL, Steensma DP. Platelet pathology in sex-linked GATA-1 dyserythropoietic macrothrombocytopenia I ultrastructure. Platelets. 2007 Jun; 18(4):273-83. PMID: 17538848.
    View in: PubMed
  290. Steensma DP. Erythropoiesis stimulating agents. BMJ. 2007 Mar 31; 334(7595):648-9. PMID: 17395907; PMCID: PMC1839202.
  291. Steensma DP. Processes to activate phase III clinical trials in a cooperative oncology group: the elephant is monstrous. J Clin Oncol. 2007 Mar 20; 25(9):1148; author reply 1148-9. PMID: 17369584.
    View in: PubMed
  292. Loprinzi CL, Barton DL, Jatoi A, Sloan J, Martenson J, Steensma D, Rao R, Novotny P, Sood A, Grothey A, Minasian L, Windschitl H. Symptom control trials: a 20-year experience. J Support Oncol. 2007 Mar; 5(3):119-25, 128. PMID: 17410810.
    View in: PubMed
  293. Kreuziger LM, Porcher JC, Ketterling RP, Steensma DP. An MLL-SEPT9 fusion and t(11;17)(q23;q25) associated with de novo myelodysplastic syndrome. Leuk Res. 2007 Aug; 31(8):1145-8. PMID: 17250889; PMCID: PMC2768487.
  294. Shampo MA, Kyle RA, Steensma DP. Leopold Ruzicka--1939 Nobel Prize in chemistry. Mayo Clin Proc. 2007 Jan; 82(1):1p preceeding table of contents. PMID: 17285778.
    View in: PubMed
  295. Steensma DP, Kyle RA. A history of the kidney in plasma cell disorders. Contrib Nephrol. 2007; 153:5-24. PMID: 17075221.
    View in: PubMed
  296. Steensma DP, Tefferi A. Risk-based management of myelodysplastic syndrome. Oncology (Williston Park). 2007 Jan; 21(1):43-54; discussion 57-8, 62. PMID: 17313156.
    View in: PubMed
  297. Caudill JS, Sood R, Zehnder JL, Pruthi RK, Steensma DP. Severe coagulation factor V deficiency associated with an interstitial deletion of chromosome 1q. J Thromb Haemost. 2007 Mar; 5(3):626-8. PMID: 17166249.
    View in: PubMed
  298. Phillips JD, Steensma DP, Pulsipher MA, Spangrude GJ, Kushner JP. Congenital erythropoietic porphyria due to a mutation in GATA1: the first trans-acting mutation causative for a human porphyria. Blood. 2007 Mar 15; 109(6):2618-21. PMID: 17148589; PMCID: PMC1852202.
  299. Steensma DP, Caudill JS, Pardanani A, McClure RF, Lasho TL, Tefferi A. MPL W515 and JAK2 V617 mutation analysis in patients with refractory anemia with ringed sideroblasts and an elevated platelet count. Haematologica. 2006 Dec; 91(12 Suppl):ECR57. PMID: 17194663.
    View in: PubMed
  300. Thompson CA, Steensma DP. Pure red cell aplasia associated with thymoma: clinical insights from a 50-year single-institution experience. Br J Haematol. 2006 Nov; 135(3):405-7. PMID: 17032177.
    View in: PubMed
  301. Mesa RA, Tefferi A, Li CY, Steensma DP. Hematologic and cytogenetic response to lenalidomide monotherapy in acute myeloid leukemia arising from JAK2(V617F) positive, del(5)(q13q33) myelodysplastic syndrome. Leukemia. 2006 Nov; 20(11):2063-4. PMID: 16990762.
    View in: PubMed
  302. Steensma DP. JAK2 V617F in myeloid disorders: molecular diagnostic techniques and their clinical utility: a paper from the 2005 William Beaumont Hospital Symposium on Molecular Pathology. J Mol Diagn. 2006 Sep; 8(4):397-411; quiz 526. PMID: 16931578; PMCID: PMC1867618.
  303. Knox SK, Kurtin PJ, Steensma DP. Isolated splenic sinus histiocytosis (Rosai-Dorfman disease) in association with myelodysplastic syndrome. J Clin Oncol. 2006 Aug 20; 24(24):4027-8. PMID: 16921057.
    View in: PubMed
  304. Mesa RA, Tefferi A, Lasho TS, Loegering D, McClure RF, Powell HL, Dai NT, Steensma DP, Kaufmann SH. Janus kinase 2 (V617F) mutation status, signal transducer and activator of transcription-3 phosphorylation and impaired neutrophil apoptosis in myelofibrosis with myeloid metaplasia. Leukemia. 2006 Oct; 20(10):1800-8. PMID: 16871275.
    View in: PubMed
  305. Steensma DP, Hecksel KA, Porcher JC, Lasho TL. Candidate gene mutation analysis in idiopathic acquired sideroblastic anemia (refractory anemia with ringed sideroblasts). Leuk Res. 2007 May; 31(5):623-8. PMID: 16870250.
    View in: PubMed
  306. Pardanani AD, Levine RL, Lasho T, Pikman Y, Mesa RA, Wadleigh M, Steensma DP, Elliott MA, Wolanskyj AP, Hogan WJ, McClure RF, Litzow MR, Gilliland DG, Tefferi A. MPL515 mutations in myeloproliferative and other myeloid disorders: a study of 1182 patients. Blood. 2006 Nov 15; 108(10):3472-6. PMID: 16868251.
    View in: PubMed
  307. Thurmes PJ, Steensma DP. Elevated serum erythropoietin levels in patients with Budd-Chiari syndrome secondary to polycythemia vera: clinical implications for the role of JAK2 mutation analysis. Eur J Haematol. 2006 Jul; 77(1):57-60. PMID: 16827884.
    View in: PubMed
  308. Shampo MA, Kyle RA, Steensma DP. William Murphy--Nobel Prize for the treatment of pernicious anemia. Mayo Clin Proc. 2006 Jun; 81(6):726. PMID: 16770970.
    View in: PubMed
  309. Caudill JS, Sternberg AJ, Li CY, Tefferi A, Lasho TL, Steensma DP. C-terminal nucleophosmin mutations are uncommon in chronic myeloid disorders. Br J Haematol. 2006 Jun; 133(6):638-41. PMID: 16704439.
    View in: PubMed
  310. Steensma DP, McClure RF, Karp JE, Tefferi A, Lasho TL, Powell HL, DeWald GW, Kaufmann SH. JAK2 V617F is a rare finding in de novo acute myeloid leukemia, but STAT3 activation is common and remains unexplained. Leukemia. 2006 Jun; 20(6):971-8. PMID: 16598306.
    View in: PubMed
  311. Steensma DP, Loprinzi CL. Epoetin alfa and darbepoetin alfa go head to head. J Clin Oncol. 2006 May 20; 24(15):2233-6. PMID: 16710021.
    View in: PubMed
  312. Steensma DP. Working against the grain. Ann Intern Med. 2006 May 02; 144(9):697-8. PMID: 16670142.
    View in: PubMed
  313. Shampo MA, Kyle RA, Steensma DP. Stamp vignette on medical science. William F. Giauque--Nobel Prize for low-temperature research. Mayo Clin Proc. 2006 May; 81(5):587. PMID: 16706253.
    View in: PubMed
  314. Steensma DP, Molina R, Sloan JA, Nikcevich DA, Schaefer PL, Rowland KM, Dentchev T, Novotny PJ, Tschetter LK, Alberts SR, Hogan TF, Law A, Loprinzi CL. Phase III study of two different dosing schedules of erythropoietin in anemic patients with cancer. J Clin Oncol. 2006 Mar 01; 24(7):1079-89. PMID: 16505427.
    View in: PubMed
  315. Steensma DP, Tefferi A. Blood vessels everywhere, but so few cells to fill them. Leuk Lymphoma. 2006 Mar; 47(3):377-8. PMID: 16396758.
    View in: PubMed
  316. Costa DB, Fisher CA, Miller KB, Pihan GA, Steensma DP, Gibbons RJ, Higgs DR. A novel mutation in the last exon of ATRX in a patient with alpha-thalassemia myelodysplastic syndrome. Eur J Haematol. 2006 May; 76(5):432-5, 453. PMID: 16480427.
    View in: PubMed
  317. Steensma DP, Pardanani A, Stevenson WS, Hoyt R, Kiu H, Grigg AP, Szer J, Juneja S, Hilton DJ, Alexander WS, Roberts AW. More on Myb in myelofibrosis: molecular analyses of MYB and EP300 in 55 patients with myeloproliferative disorders. Blood. 2006 Feb 15; 107(4):1733-5; author reply 1735. PMID: 16461764; PMCID: PMC1895422.
  318. Nelson ME, Steensma DP. JAK2 V617F in myeloid disorders: what do we know now, and where are we headed? Leuk Lymphoma. 2006 Feb; 47(2):177-94. PMID: 16321848.
    View in: PubMed
  319. Steensma DP. Luis Walter Alvarez: another "Mayo-trained" Nobel Laureate. Mayo Clin Proc. 2006 Feb; 81(2):241-4. PMID: 16471081.
    View in: PubMed
  320. Steensma DP. Are myelodysplastic syndromes "cancer"? Unexpected adverse consequences of linguistic ambiguity. Leuk Res. 2006 Oct; 30(10):1227-33. PMID: 16443272.
    View in: PubMed
  321. Steensma DP, Bennett JM. The myelodysplastic syndromes: diagnosis and treatment. Mayo Clin Proc. 2006 Jan; 81(1):104-30. PMID: 16438486.
    View in: PubMed
  322. Kaufmann SH, Steensma DP. On the TRAIL of a new therapy for leukemia. Leukemia. 2005 Dec; 19(12):2195-202. PMID: 16224489.
    View in: PubMed
  323. Nelson ME, Thurmes PJ, Hoyer JD, Steensma DP. A novel 5' ATRX mutation with splicing consequences in acquired alpha thalassemia-myelodysplastic syndrome. Haematologica. 2005 Nov; 90(11):1463-70. PMID: 16266892.
    View in: PubMed
  324. Tefferi A, Lasho TL, Schwager SM, Steensma DP, Mesa RA, Li CY, Wadleigh M, Gary Gilliland D. The JAK2(V617F) tyrosine kinase mutation in myelofibrosis with myeloid metaplasia: lineage specificity and clinical correlates. Br J Haematol. 2005 Nov; 131(3):320-8. PMID: 16225651.
    View in: PubMed
  325. Shampo MA, Kyle RA, Steensma DP. Sir Charles Sherrington--"The William Harvey of the nervous system". Mayo Clin Proc. 2005 Oct; 80(10):1266. PMID: 16212136.
    View in: PubMed
  326. Tefferi A, Sirhan S, Lasho TL, Schwager SM, Li CY, Dingli D, Wolanskyj AP, Steensma DP, Mesa R, Gilliland DG. Concomitant neutrophil JAK2 mutation screening and PRV-1 expression analysis in myeloproliferative disorders and secondary polycythaemia. Br J Haematol. 2005 Oct; 131(2):166-71. PMID: 16197445.
    View in: PubMed
  327. Loprinzi C, Steensma D. The questions of prognosis. J Support Oncol. 2005 Sep-Oct; 3(5):340-1. PMID: 16218256.
    View in: PubMed
  328. Steensma DP, Witzig TE. Does treatment with recombinant human erythropoietin affect the survival of anemic patients with cancer? Nat Clin Pract Oncol. 2005 Sep; 2(9):444-5. PMID: 16265012.
    View in: PubMed
  329. Steensma DP, Loprinzi CL. Erythropoietin use in cancer patients: a matter of life and death? J Clin Oncol. 2005 Sep 01; 23(25):5865-8. PMID: 16087951.
    View in: PubMed
  330. Steensma DP, Molina R, Sloan JA, Nikcevich DA, Schaefer PL, Rowland KM, Dentchev T, Tschetter LK, Novotny PJ, Loprinzi CL. A phase III randomized trial of two different dosing schedules of erythropoietin (EPO) in patients with cancer-associated anemia: North Central Cancer Treatment Group (NCCTG) Study N02C2. J Clin Oncol. 2005 Jun; 23(16_suppl):8031. PMID: 27946598.
    View in: PubMed
  331. Steensma DP, List AF. Genetic testing in the myelodysplastic syndromes: molecular insights into hematologic diversity. Mayo Clin Proc. 2005 May; 80(5):681-98. PMID: 15887439.
    View in: PubMed
  332. Steensma DP. Polycythemia vera: plethora, from prehistory to present. Curr Hematol Rep. 2005 May; 4(3):230-4. PMID: 15865877.
    View in: PubMed
  333. Steensma DP, Dewald GW, Lasho TL, Powell HL, McClure RF, Levine RL, Gilliland DG, Tefferi A. The JAK2 V617F activating tyrosine kinase mutation is an infrequent event in both "atypical" myeloproliferative disorders and myelodysplastic syndromes. Blood. 2005 Aug 15; 106(4):1207-9. PMID: 15860661; PMCID: PMC1895198.
  334. Steensma DP, Shampo MA, Kyle RA. Cecilia Makiwane--pioneer African nurse. Mayo Clin Proc. 2005 Apr; 80(4):449. PMID: 15819279.
    View in: PubMed
  335. Shanafelt TD, Novotny P, Johnson ME, Zhao X, Steensma DP, Lacy MQ, Rubin J, Sloan J. The well-being and personal wellness promotion strategies of medical oncologists in the North Central Cancer Treatment Group. Oncology. 2005; 68(1):23-32. PMID: 15775690.
    View in: PubMed
  336. Steensma DP. Down syndrome in Down House: trisomy 21, GATA1 mutations, and Charles Darwin. Blood. 2005 Mar 15; 105(6):2614-6. PMID: 15746086.
    View in: PubMed
  337. Steensma DP, Gibbons RJ, Mesa RA, Tefferi A, Higgs DR. Somatic point mutations in RUNX1/CBFA2/AML1 are common in high-risk myelodysplastic syndrome, but not in myelofibrosis with myeloid metaplasia. Eur J Haematol. 2005 Jan; 74(1):47-53. PMID: 15613106.
    View in: PubMed
  338. Steensma DP. Northwoods elegy. Ann Intern Med. 2004 Oct 05; 141(7):573-4. PMID: 15466777.
    View in: PubMed
  339. Shampo MA, Kyle RA, Steensma DP. Ferid Murad--1998 Nobel laureate for nitric oxide research. Mayo Clin Proc. 2004 Oct; 79(10):1230. PMID: 15473401.
    View in: PubMed
  340. Steensma DP, Gibbons RJ, Higgs DR. Acquired alpha-thalassemia in association with myelodysplastic syndrome and other hematologic malignancies. Blood. 2005 Jan 15; 105(2):443-52. PMID: 15358626.
    View in: PubMed
  341. Fisher C, Steensma D, Janmohamed R, Kaczmarski R, Reilly JT, Vyas P. Absence of mutations in the key megakaryocyte transcriptional regulator FOG-1 in patients with idiopathic myelofibrosis. Br J Haematol. 2004 Sep; 126(5):750-2. PMID: 15327530.
    View in: PubMed
  342. Steensma DP. Myelodysplasia, megakaryocytes, and methylation. Leuk Res. 2004 Aug; 28(8):775-6. PMID: 15203274.
    View in: PubMed
  343. Steensma DP. Reassurance. J Clin Oncol. 2004 Aug 01; 22(15):3196-8. PMID: 15284275.
    View in: PubMed
  344. Steensma DP. Management of anemia in patients with cancer. Curr Oncol Rep. 2004 Jul; 6(4):297-304. PMID: 15161584.
    View in: PubMed
  345. Steensma DP. The symbol of modern medicine. Ann Intern Med. 2004 Feb 17; 140(4):311; author reply 311-2. PMID: 14970165.
    View in: PubMed
  346. Steensma DP. Enough already of the word "robust"! Blood. 2004 Jan 15; 103(2):746-7. PMID: 14702290.
    View in: PubMed
  347. Steensma DP, Higgs DR, Fisher CA, Gibbons RJ. Acquired somatic ATRX mutations in myelodysplastic syndrome associated with alpha thalassemia (ATMDS) convey a more severe hematologic phenotype than germline ATRX mutations. Blood. 2004 Mar 15; 103(6):2019-26. PMID: 14592816.
    View in: PubMed
  348. Steensma DP, Viprakasit V, Hendrick A, Goff DK, Leach J, Gibbons RJ, Higgs DR. Deletion of the alpha-globin gene cluster as a cause of acquired alpha-thalassemia in myelodysplastic syndrome. Blood. 2004 Feb 15; 103(4):1518-20. PMID: 14576055.
    View in: PubMed
  349. Mesa RA, Steensma DP, Hoyer J, Ketterling RP. Concomitant myelodysplastic syndrome and chronic myeloid leukaemia: treatment outcomes with imatinib mesylate. Br J Haematol. 2003 Oct; 123(2):366-7. PMID: 14531922.
    View in: PubMed
  350. Steensma DP, Mesa RA, Reeder TL, Tefferi A, Kaufmann SH. Effects of the MEK inhibitor CI-1040 (PD 184352) on progenitor growth from normal and myelodysplastic marrow. Haematologica. 2003 Sep; 88(9):1072-4. PMID: 12969818.
    View in: PubMed
  351. Steensma DP, Tefferi A, Li CY. Splenic histopathological patterns in chronic myelomonocytic leukemia with clinical correlations: reinforcement of the heterogeneity of the syndrome. Leuk Res. 2003 Sep; 27(9):775-82. PMID: 12804634.
    View in: PubMed
  352. Steensma DP. The In-Training Examination in Internal Medicine. Ann Intern Med. 2003 Jun 17; 138(12):1009; author reply 1010-1. PMID: 12809470.
    View in: PubMed
  353. Daugherty CK, Steensma DP. Overcoming obstacles to hospice care: an ethical examination of inertia and inaction. J Clin Oncol. 2003 May 01; 21(9 Suppl):42s-45s. PMID: 12743190.
    View in: PubMed
  354. Steensma DP. The narrow path. J Clin Oncol. 2003 May 01; 21(9 Suppl):57s-60s; discussion 60s. PMID: 12743195.
    View in: PubMed
  355. Steensma DP. Submitting to autonomy. J Clin Oncol. 2003 May 01; 21(9 Suppl):62s-63s. PMID: 12743197.
    View in: PubMed
  356. Steensma DP. The chronic myeloproliferative disorders: an historical perspective. Curr Hematol Rep. 2003 May; 2(3):221-30. PMID: 12901343.
    View in: PubMed
  357. Steensma DP. Why me? J Clin Oncol. 2003 May 01; 21(9 Suppl):64s-66s. PMID: 12743198.
    View in: PubMed
  358. Steensma DP, Dewald GW, Hodnefield JM, Tefferi A, Hanson CA. Clonal cytogenetic abnormalities in bone marrow specimens without clear morphologic evidence of dysplasia: a form fruste of myelodysplasia? Leuk Res. 2003 Mar; 27(3):235-42. PMID: 12537976.
    View in: PubMed
  359. Steensma DP. The kiss of death: a severe allergic reaction to a shellfish induced by a good-night kiss. Mayo Clin Proc. 2003 Feb; 78(2):221-2. PMID: 12583533.
    View in: PubMed
  360. Steensma DP. "Pawn Ball Megakaryocytes": from the marvellous medici and dear Old Saint Nick to the unsanctified marrow of myelodysplasia. Hematology. 2003 Feb; 8(1):11-8. PMID: 12623422.
    View in: PubMed
  361. Steensma DP, Tefferi A. The myelodysplastic syndrome(s): a perspective and review highlighting current controversies. Leuk Res. 2003 Feb; 27(2):95-120. PMID: 12526916.
    View in: PubMed
  362. Steensma DP. Eureka moments. Pharos Alpha Omega Alpha Honor Med Soc. 2003; 66(4):43. PMID: 14725193.
    View in: PubMed
  363. Steensma DP, Timm M, Witzig TE. Flow cytometric methods for detection and quantification of apoptosis. Methods Mol Med. 2003; 85:323-32. PMID: 12710217.
    View in: PubMed
  364. Mesa RA, Steensma DP, Pardanani A, Li CY, Elliott M, Kaufmann SH, Wiseman G, Gray LA, Schroeder G, Reeder T, Zeldis JB, Tefferi A. A phase 2 trial of combination low-dose thalidomide and prednisone for the treatment of myelofibrosis with myeloid metaplasia. Blood. 2003 Apr 01; 101(7):2534-41. PMID: 12517815.
    View in: PubMed
  365. Steensma DP, Dispenzieri A, Moore SB, Schroeder G, Tefferi A. Antithymocyte globulin has limited efficacy and substantial toxicity in unselected anemic patients with myelodysplastic syndrome. Blood. 2003 Mar 15; 101(6):2156-8. PMID: 12411290.
    View in: PubMed
  366. Steensma DP. The other résumé. Ann Intern Med. 2002 Oct 01; 137(7):623. PMID: 12353962.
    View in: PubMed
  367. Steensma DP. John Calvin and Michael Servetus: tragic clash of reformer and radical physician. Scalpel Tongs. 2002 Oct-Dec; 46(1):14-9. PMID: 12572555.
    View in: PubMed
  368. Steensma DP, Hook CC, Stafford SL, Tefferi A. Low-dose, single-fraction, whole-lung radiotherapy for pulmonary hypertension associated with myelofibrosis with myeloid metaplasia. Br J Haematol. 2002 Sep; 118(3):813-6. PMID: 12181050.
    View in: PubMed
  369. Daugherty CK, Steensma DP. Overcoming obstacles to hospice care: an ethical examination of inertia and inaction. J Clin Oncol. 2002 Jun 01; 20(11):2752-5. PMID: 12039940.
    View in: PubMed
  370. Tefferi A, Mesa RA, Gray LA, Steensma DP, Camoriano JK, Elliott MA, Pardanani A, Ansell SM, Call TG, Colon-Otero G, Schroeder G, Hanson CA, Dewald GW, Kaufmann SH. Phase 2 trial of imatinib mesylate in myelofibrosis with myeloid metaplasia. Blood. 2002 May 15; 99(10):3854-6. PMID: 11986248.
    View in: PubMed
  371. Steensma DP, Mesa RA, Li CY, Gray L, Tefferi A. Etanercept, a soluble tumor necrosis factor receptor, palliates constitutional symptoms in patients with myelofibrosis with myeloid metaplasia: results of a pilot study. Blood. 2002 Mar 15; 99(6):2252-4. PMID: 11877307.
    View in: PubMed
  372. Steensma DP. Why me? J Clin Oncol. 2002 Feb 01; 20(3):873-5. PMID: 11821476.
    View in: PubMed
  373. Steensma DP, Tefferi A. Cytogenetic and molecular genetic aspects of essential thrombocythemia. Acta Haematol. 2002; 108(2):55-65. PMID: 12187022.
    View in: PubMed
  374. Steensma DP, Tefferi A. Myelodysplastic syndrome and pregnancy: the Mayo Clinic experience. Leuk Lymphoma. 2001 Nov-Dec; 42(6):1229-34. PMID: 11911403.
    View in: PubMed
  375. Steensma DP, Harrison CN, Tefferi A. Hydroxyurea-associated platelet count oscillations in polycythemia vera: a report of four new cases and a review. Leuk Lymphoma. 2001 Nov-Dec; 42(6):1243-53. PMID: 11911405.
    View in: PubMed
  376. Steensma DP, Hanson CA, Letendre L, Tefferi A. Myelodysplasia with fibrosis: a distinct entity? Leuk Res. 2001 Oct; 25(10):829-38. PMID: 11532514.
    View in: PubMed
  377. Steensma DP, Letendre L, Tefferi A. Clarifications to the standard neutrophil response criteria for clinical trials in myelodysplastic syndromes are needed. Blood. 2001 May 15; 97(10):3321-2. PMID: 11368066.
    View in: PubMed
  378. Steensma DP, Gertz MA, Greipp PR, Kyle RA, Lacy MQ, Lust JA, Offord JR, Plevak MF, Therneau TM, Witzig TE. A high bone marrow plasma cell labeling index in stable plateau-phase multiple myeloma is a marker for early disease progression and death. Blood. 2001 Apr 15; 97(8):2522-3. PMID: 11290618.
    View in: PubMed
  379. Steensma DP. The narrow path. J Clin Oncol. 2001 Apr 01; 19(7):2102-5. PMID: 11283147.
    View in: PubMed
  380. Steensma DP, Hoyer JD, Fairbanks VF. Hereditary red blood cell disorders in middle eastern patients. Mayo Clin Proc. 2001 Mar; 76(3):285-93. PMID: 11243275.
    View in: PubMed
  381. Steensma DP. "Congo" red: out of Africa? Arch Pathol Lab Med. 2001 Feb; 125(2):250-2. PMID: 11175644.
    View in: PubMed
  382. Tefferi A, Elliott MA, Steensma DP, Hook CC, Dispenzieria A, Hanson CA, Schroeder G, Letendre L. Amifostine alone and in combination with erythropoietin for the treatment of favorable myelodysplastic syndrome. Leuk Res. 2001 Feb; 25(2):183-5. PMID: 11166835.
    View in: PubMed
  383. Steensma DP. Submitting to autonomy. J Clin Oncol. 2000 Nov 01; 18(21):3736-7. PMID: 11054449.
    View in: PubMed
  384. Steensma DP, Loprinzi CL. The art and science of prognosis in patients with advanced cancer. Eur J Cancer. 2000 Oct; 36(16):2025-7. PMID: 11044637.
    View in: PubMed
  385. Steensma DP. Sister (Mary) Joseph's nodule. Ann Intern Med. 2000 Aug 01; 133(3):237. PMID: 10906845.
    View in: PubMed
  386. Steensma DP, Tefferi A, Weiler CR. Autoimmune hemolytic anemia in a patient with autosomal dominant chronic mucocutaneous candidiasis. Mayo Clin Proc. 2000 Aug; 75(8):853-5. PMID: 10943243.
    View in: PubMed
  387. Habermann TM, Steensma DP. Lymphadenopathy. Mayo Clin Proc. 2000 Jul; 75(7):723-32. PMID: 10907389.
    View in: PubMed
  388. Steensma DP, Morice WG. Littoral cell angioma associated with portal hypertension and resected colon cancer. Acta Haematol. 2000; 104(2-3):131-4. PMID: 11154990.
    View in: PubMed
  389. Steensma DP, Witzig TE. Elevated serum LDH in patients with non-Hodgkin's lymphoma: not always an ominous sign. Br J Haematol. 1999 Nov; 107(2):463-4. PMID: 10583243.
    View in: PubMed
  390. Steensma DP. Fifty years of Tart cells. Mayo Clin Proc. 1999 Sep; 74(9):936-8. PMID: 10488799.
    View in: PubMed
  391. Steensma DP, Matteson EL. 80-year-old woman with dizziness. Mayo Clin Proc. 1997 Aug; 72(8):781-4. PMID: 9276607.
    View in: PubMed
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Steensma's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (959)
Explore
_
Co-Authors (134)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
Funded by the NIH/NCATS Clinical and Translational Science Award (CTSA) program, grant number UL1TR001102, and through institutional support from Harvard University, Harvard Medical School, Harvard T.H. Chan School of Public Health, Beth Israel Deaconess Medical Center, Boston Children's Hospital, Brigham and Women's Hospital, Massachusetts General Hospital and the Dana Farber Cancer Institute.